Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Wiley Interdiscip Rev Dev Biol. 2015 Oct 8;5(2):233–267. doi: 10.1002/wdev.214

Genome Engineering: Drosophila melanogaster and beyond

Koen JT Venken 1,2,3,4,#, Alejandro Sarrion-Perdigones 1, Paul J Vandeventer 1, Nicholas S Abel 2, Audrey E Christiansen 1, Kristi L Hoffman 1
PMCID: PMC4761275  NIHMSID: NIHMS718151  PMID: 26447401

Abstract

A central challenge to investigating biological phenomena is the development of techniques to modify genomic DNA with nucleotide precision that can be transmitted through the germ line. Recent years have brought a boon in these technologies, now collectively known as genome engineering. Defined genomic manipulations at the nucleotide level enable a variety of reverse engineering paradigms, providing new opportunities to interrogate diverse biological functions. These genetic modifications include controlled removal, insertion, and substitution of genetic fragments, both small and large. Small fragments up to a few kilobases (e.g., single nucleotide mutations, small deletions, or gene tagging at single or multiple gene loci) to large fragments up to megabase resolution can be manipulated at single loci to create deletions, duplications, inversions, or translocations of substantial sections of whole chromosome arms. A specialized substitution of chromosomal portions that presumably are functionally orthologous between different organisms through syntenic replacement, can provide proof of evolutionary conservation between regulatory sequences. Large transgenes containing endogenous or synthetic DNA can be integrated at defined genomic locations, permitting an alternative proof of evolutionary conservation, and sophisticated transgenes can be used to interrogate biological phenomena. Precision engineering can additionally be used to manipulate the genomes of organelles (e.g., mitochondria). Novel genome engineering paradigms are often accelerated in existing, easily genetically tractable model organisms, primarily because these paradigms can be integrated in a rigorous, existing technology foundation. The Drosophila melanogaster fly model is ideal for these types of studies. Due to its small genome size, having just four chromosomes, the vast amount of cutting-edge genetic technologies, and its short life-cycle and inexpensive maintenance requirements, the fly is exceptionally amenable to complex genetic analysis using advanced genome engineering. Thus, highly sophisticated methods developed in the fly model can be used in nearly any sequenced organism. Here, we summarize different ways to perform precise inheritable genome engineering using integrases, recombinases, and DNA nucleases in the D. melanogaster.

2. Introduction

Genome engineering is collectively defined as the technologies and methods used to modify an organism’s genetic material in a defined manner. So far, extensive genome engineering has been performed in prokaryotes and single celled eukaryotes1,2, e.g., synthetic version of entire genomes of the bacteria Mycoplasma genitalium3 and Mycoplasma mycoides3, and a full chromosome of the yeast Saccharomyces cerevisiae4,5 have been generated and manipulated. Primarily due to their greater complexity, similar manipulations in larger, multicellular animals have historically lagged behind. In recent years, however, our ability to modify the genomes of higher organisms has expanded tremendously, becoming ever more precise and defined to nucleotide resolution6,7. While these efforts have largely been directed toward the nuclear genome, some can also target DNA-containing organelles (e.g., mitochondria)810. Importantly, changes introduced by genome engineering allow scientists to better recapitulate known genetic dysfunctions and interrogate their consequences at any biological level (Fig. 1).

Figure 1. Overview of Phenotype Analysis and Genome Engineering at Different Levels in Animal Model Systems.

Figure 1

A. The biology level. Mutant phenotypes and DNA modifications can be analyzed at systems-, tissue-, cell-, subcellular-, and molecular levels. B. The DNA level. DNA modifications can be performed at genome-, chromosome-, subchromosome-, chromatin-, or nucleotide-levels. C. Methods to perform genome engineering at the different DNA levels. Currently, engineering technologies to manipulate genomes or chromosomes in toto are unavailable for Drosophila melanogaster or any other multicellular eukaryotic organism. On the other hand, numerous methods are available to precisely engineer chromosomal sections, gene environments, and gene properties. Note: Drawings for panel B were acquired by modifying free vector templates available from www.vector.me.

Most whole-animal genome engineering paradigms focus on well-studied model organisms, both invertebrates, e.g., the worm Caenorhabditis elegans11 and the fly Drosophila melanogaster1216, and vertebrates, e.g., the mouse Mus musculus17,18, the rat Rattus norvegicus19,20, and the zebrafish Danio rerio21,22. Due to evolutionary conservation of cellular and developmental signaling pathways, findings from model organisms often provide insight into the function (and malfunction) of other animal species that are less amenable to genome engineering23. Ideal model organisms are easily amenable to experimental manipulation, exhibit a short life-cycle, and require minimal (and reasonably inexpensive) maintenance24,25. Moreover, they frequently have a substantial pre-existing experimental toolkit encompassing a wide portfolio of techniques for somatic genetic manipulation, germline mutagenesis, genome engineering, differential cellular labeling, whole tissue analysis, and systems physiology interrogation23. Hence, small model organisms, notably C. elegans11, and D. melanogaster1216, provide valuable platforms for sophisticated biological studies, including those relevant to human disease12,26,27.

The fly in particular is a powerful model system that has contributed enormously to our understanding of genetics, developmental biology, neurobiology, and more recently, to factors leading to human discomfort and disease12,2729. Importantly, many pathways responsible for disease and mutant phenotype ontogenesis (e.g., notch, hedgehog and hippo) were first discovered and characterized in D. melanogaster28,30. The fly has also been a powerful model to study intrinsic processes that constitute disease and mutant phenotype formation12,31,32, such as DNA instability, tissue growth, cell invasion, and other well-known hallmarks of cancer3335. Several of these hallmarks also have significant relevance in other diseases36. Importantly, sequencing of the entire Drosophila genome37, recently updated to its sixth version38, accelerated the development of several cutting-edge genetic technology innovations that can be adapted and combined to create ever more powerful genetic paradigms, including tools for genetic manipulation, genome engineering, and disease modeling1216,39. Moreover, systems pharmacology using flies can identify optimal therapeutic drugs12,31,40,41. Finally, in vivo genome-wide analysis of tractable disease development using complex genetic backgrounds within defined, labeled cell populations is most advanced in flies42,43. Based on these advantages, Drosophila is currently unsurpassed as a multicellular organism for gene discovery, genetic manipulation, and disease modeling12,15,16,32. Recent genome engineering innovations founded on recombinases44, integrases4547, and programmable nucleases39,48,49, have made it possible to further expand the paradigms for sophisticated targeted genome manipulations.

Herein we discuss aspects of precision genome engineering, i.e., genome manipulation at nucleotide resolution, in the fly D. melanogaster. When introduced in the germ line, such manipulations can be maintained over generations through convenient crossing schemes. We will first examine the different components of precision engineering paradigms, summarizing key enzymes (recombinases, integrases, and a variety of nucleases) used to edit the genome and the mechanisms by which they do so. Next, we review how genome engineering is experimentally achieved, outlining commonly used methods used to introduce genetic modifications. Finally, we summarize various outcomes of genome engineering paradigms, reviewing changes both small (e.g., single nucleotide substitutions or kb-sized deletions or insertions) and large (e.g., multi-kilobase inversions or translocations), as well as specialized modifications such as syntenic replacement. We also examine paradigms geared toward the addition of novel genetic material via site-specific transgenesis and briefly touch on the manipulation of organellar genomes.

3. Molecular Players and Reaction Outcomes in Genome Engineering

Precise genome engineering can be carried out by a number of enzymes, including a plethora of recombinases44 and integrases45, and a variety of nucleases48. Although these enzymes catalyze different types of reactions, they all exhibit one key feature: the ability to bind DNA at a predetermined recognition site. The specificity of a given enzyme for its recognition site is critical to the success of genome engineering since it determines specificity of the enzymatic reaction. For recombinases, integrases, and meganucleases, the recognition site is defined by the enzyme itself. In contrast, recognition sites for zinc finger and transcription activator-like effector nucleases are user-defined and set by varying the enzyme’s amino acid sequence. RNA-guided nucleases are also custom designed by the researcher but use a complementary RNA molecule to target the DNA sequence of interest.

To precisely edit the genome, engineering enzymes must catalyze one of two types of reactions. Recombinases and integrases, which induce recombination and integration events, respectively, catalyze an exchange reaction between two DNA templates, each containing an enzyme-specific recognition site4447. In contrast, nucleases cut DNA at a precise location and exploit cellular repair mechanisms to complete genome modification39,48,49.

3.1 Recombinases and Integrases

As enzymes for precision genome engineering, recombinases and integrases are very similar. They both use short, enzyme-defined recognition sites, and both catalyze an exchange reaction between two DNA substrates4447. In both recombination and integration events, the DNA exchange reforms the recognition sites, though they may be nonfunctional for future exchange events. Numerous recombinases and integrases are available for DNA manipulation.

A. Recombinases

Recombinases were one of the first enzymes used for precise genome engineering and have been used extensively in a number of model organisms, including the fly14,44,50. As their name suggests, recombinases catalyze a recombination reaction between two DNA templates, each containing a 30–40 bp enzyme-specific recognition site, e.g., minimal LOcus of crossing (X) over, P1 (LoxP) and FLP recombinase Recognition Target (FRT) sites are 34 bp long44,51. These recognition sites contain perfect inverted repeats flanking an asymmetric spacer (Fig. 2A and Table 1). Under normal conditions the recognition sites are identical and the reactions they catalyze bidirectional. That is, since the outcome of any recombination event is reformation of the same two recognition sites, recombination can proceed in both “forward” and “reverse” directions44 (Fig. 2A and 2B). However, recognition sites can be altered to drive the reaction directionality (Table 1). For example, recombination between a site with a mutation in its left-side inverted repeat and one with a mutation in its right-side inverted repeat will produce two new recognition sites—one inverted repeat double mutant site and one wild type—that can no longer recombine52,53. Such sites are called inverted repeat mutants51 (Fig. 2B). Non-compatible or orthogonal (i.e., mutually exclusive) recognition sites have also been engineered for some recombinase family members5457 (Table 1). These sites contain mutations in the asymmetric spacer of the recombinase recognition site and are therefore called spacer mutants51 (Fig. 2B). Spacer mutant sites allow multiple, simultaneous independent recombination events using the same enzyme58 (Fig. 2B).

Figure 2. Recombinases.

Figure 2

A. Molecular reaction performed by the Cre recombinase. B. Comparison of mutant and wild type recombination recognition sites. Inverted repeat mutant- and spacer mutant recombination recognition sites are indicated. C. Outcomes of recombination reactions using wild type-, inverted repeat mutant-, and spacer mutant recombination sites. Recombination reactions can result in inversion, excision, integration, or recombinase-mediated cassette exchange (RMCE) events. Reaction directionality, i.e., uni- or bidirectional, using different recombination site classes is indicated.

Table 1.

Recombinases.

Recombinase Target Site Sequencea
Cre LoxP 5’-ATAACTTCGTATAatgtatgcTATACGAAGTTAT-3’
Lox2272 5’-ATAACTTCGTATAaagtatccTATACGAAGTTAT-3’
Loxm2 5’-ATAACTTCGTATAagaaaccaTATACGAAGTTAT-3’
LoxLE 5’-TACCGTTCGTATAatgtatgcTATACGAAGTTAT-3’
LoxRE 5’-ATAACTTCGTATAatgtatgcTATACGAACGGTA-3’
Fre LoxH 5’-ATATATACGTATAtatgtctaTATACGTATATAT-3’
Tre LoxLTR 5’-ACAACATCCTATTacaccctaTATGCCAACATGG-3’
FLP FRT 5’-GAAGTTCCTATTCtctagaaaGTATAGGAACTTC-3’
F3 5’-GAAGTTCCTATTCttcaaataGTATAGGAACTTC-3’
F5 5’-GAAGTTCCTATTCttcaaaagGTATAGGAACTTC-3’
FRT-LE 5’-GAAGTTCATATTCtctagaaaGTATAGGAACTTC-3’
FRT-RE 5’-GAAGTTCCTATTCtctagaaaGTATATGAACTTC-3’
mFlp5 mFRT71 5’-GAAGTTTCTATTCtctagaaaGTATAGAAACTTC-3’
Dre Rox 5’-TAACTTTAAATAATgccaATTATTTAAAGTTA-3’
KD KDRT 5’-AAACGATATCAGACATTTGTCTGATAATgcttcATTATCAGACAAATGTCTGATATCGTTT-3’
B2 B2RT 5’-GAGTTTCATTAAGGAATaactaATTCCCTAATGAAACTC-3’
B3 B3RT 5’-GGTTGCTTAAGAATaagtaATTCTTAAGCAACC-3’
R RSRT 5’-TTGATGAAAGAATAacgTATTCTTTCATCAA-3’
VCre VloxP 5’-TCAATTTCTGAGAactgtcatTCTCGGAAATTGA-3’
SCre SloxP 5’-CTCGTGTCCGATAactgtaatTATCGGACATGAT-3’
Vika Vox 5’-AATAGGTCTGAGAacgcccatTCTCAGACGTATT-3’
a

Inverted repeats are in capital, spacers are in lower case, mutations compared to wild type site are highlighted in red

The most commonly used recombinases in eukaryotic genome engineering are Cre (Causes REcombination), which catalyzes recombination between LoxP sites, and FLP (FLiPpase), which induces recombination between FRT sites51 (Table 1). Within the fly community, Cre usage got off to a slow start59,60, partly due to toxicity6163. This toxicity can be remediated by adding an inducible hormone binding domain (e.g., estrogen receptor)62, including light inducible conditional protein domains that catalyze Cre complementation64, or limiting availability by redirecting the recombinase to the proteasome through a fused PEST domain63. Despite these challenges, several experimental paradigms have been developed using Cre in flies, e.g., chromosomal manipulations65, transgenesis66, gene targeting61, and conditional activation63,67. FLP on the other hand, was quickly adopted by the fly community14,42,50. Additional recombinases recently tested for in vivo genome modification in flies include Dre (recognizing DNA recombinase sites known as rox sites)63,68,69, KD (KDRT sites)63, B2 (B2RT sites)63, B3 (B3RT sites)63, and R (RSRT sites)63 (Table 1). Although not yet tested in flies, other recombinases such as Vika70, SCre and VCre71,72, will likely provide additional opportunities for genome engineering (Table 1).

To further expand the number of recombinases available for genome engineering, existing recombinases can be evolved to recognize novel sites not identified by their normal counterparts. Novel versions of Cre (e.g., Fre and Tre recognizing LoxH and LoxLTR sites, respectively)73,74 and FLP (e.g., mFlp5 recognizing mFRT71 sites)75,76 have been engineered through molecular evolution to function orthogonally to their normal counterparts (Table 1). Only mFlp5 has been used in flies to date75.

B. Integrases

Like recombinases, integrases catalyze an exchange reaction—an integration—between two DNA substrates, each carrying an enzyme recognition site4547. Unlike recombinases though, integrase recognition sites contain a short integration core flanked by imperfect inverted repeats that are not identical45 (Fig. 3A and Table 2). Upon integration, these sites known as attB (i.e., ATTachment site used by Bacteria) and attP (i.e., ATTachment site used by Phage), form the hybrid sites attL (i.e., ATTachment site at the Left containing the 5’ half of attP and 3’ half of attB) and attR (i.e., ATTachment site at the Right containing the 5’ half of attP and 3’ half of attB). The attL and attR sites are not substrates for integrase, conveniently driving the reaction in one direction45 (Fig. 3A). The reverse reaction, an excision, can occur but only in the presence of an appropriate excisionase45,77. Importantly, each integrase recognizes its own cognate attB and attP sites45,78 (Table 2). However, as with recombinases, orthogonal recognition sites (i.e., spacer mutants) have been engineered for some integrase family members, allowing them to catalyze multiplex integration reactions79 (Fig. 3B and Table 2).

Figure 3. Integrases.

Figure 3

A. Molecular reaction performed by the ΦC31 integrase. B. Comparison of mutant and wild type integration recognition sites. Inverted repeat mutant- and spacer mutant integration recognition sites are indicated. C. Outcomes of integration reactions using wild type- and spacer mutant integration sites. Integration reactions can result in inversion, excision, integration, or integrase-mediated cassette exchange (IMCE) events. Reaction directionality, i.e., unidirectional, using different integration site classes is indicated.

Table 2.

Integrases.

Integrase Target Site Sequencea
ΦC31 AttBTT 5’-TGCGGGTGCCAGGGCGTGCCCttGGGCTCCCCGGGCGCGTACTCC-3’
AttPTT 5’-GTGCCCCAACTGGGGTAACCTttGAGTTCTCTCAGTTGGGGG-3’
AttBCT 5’-TGCGGGTGCCAGGGCGTGCCCctGGGCTCCCCGGGCGCGTACTCC-3’
AttPCT 5’-GTGCCCCAACTGGGGTAACCTctGAGTTCTCTCAGTTGGGGG-3’
AttBGT 5’-TGCGGGTGCCAGGGCGTGCCCgtGGGCTCCCCGGGCGCGTACTCC-3’
AttPGT 5’-GTGCCCCAACTGGGGTAACCTgtGAGTTCTCTCAGTTGGGGG-3’
AttBCA 5’-TGCGGGTGCCAGGGCGTGCCCcaGGGCTCCCCGGGCGCGTACTCC-3’
AttPCA 5’-GTGCCCCAACTGGGGTAACCTcaGAGTTCTCTCAGTTGGGGG-3’
AttBCC 5’-TGCGGGTGCCAGGGCGTGCCCccGGGCTCCCCGGGCGCGTACTCC-3’
AttPCC 5’-GTGCCCCAACTGGGGTAACCTccGAGTTCTCTCAGTTGGGGG-3’
AttBTC 5’-TGCGGGTGCCAGGGCGTGCCCtcGGGCTCCCCGGGCGCGTACTCC-3’
AttPTC 5’-GTGCCCCAACTGGGGTAACCTtcGAGTTCTCTCAGTTGGGGG-3’
Bxb1 AttB 5’-TCGGCCGGCTTGTCGACGACGgcggtctcCGTCGTCAGGATCATCCGGGC-3’
AttP 5’-GTCGTGGTTTGTCTGGTCAACCACCgcggtctcAGTGGTGTACGGTACAAACCCCGAC-3’
R4 AttB 5’-GCGCCCAAGTTGCCCATGACCATGCCgaagcagtggtaGAAGGGCACCGGCAGACAC-3’
AttP 5’-AGGCATGTTCCCCAAAGCGATACCACTTgaagcagtggtaCTGCTTGTGGGTACACTCTGCGGGTGATGA-3’
a

Inverted repeats are in capital, spacers are in lower case, mutations compared to WT site are highlighted in red

The ΦC31 integrase is the most frequently used integrase for genome engineering14,15,77. Effective in many species, e.g., mouse and zebrafish8082, ΦC31 has been most extensively used in flies, where numerous genome-wide collections have been generated for RNAi83, genomic rescue8486, cellular labeling87, and overexpression studies88,89. Bxb1 integrase was recently tested for in vivo genome modification in D. melanogaster90, but its use is not yet widespread. Many other integrases exist (e.g., ΦBT1, TG1, R4, ΦRv1, TP901-1, A118 and ΦMR11)4547,91; although they have not been tested in multicellular eukaryotes, including flies, they similarly provide tremendous opportunity to explore novel integration paradigms.

C. Reaction Outcomes

Reactions induced by recombinases and integrases can produce a variety of genetic alterations, including DNA deletions, duplications, inversions, translocations, insertions, and replacements51. The outcome of a particular recombination or integration event largely depends on properties of the enzyme recognition sequences. Recognition site orientation (e.g., direct or inverted), location (i.e., where and on which chromosome(s), and composition (i.e., wild type, inverted repeat- or spacer mutants) all influence reaction outcomes (illustrated for inversions, excisions, and integrations, Fig. 2C and 3C). While exchange reactions commonly occur between one pair of recognition sites, two pairs of sites can also be used for a total of four recognition sites. When two recognition sites on the endogenous chromosome are paired with two sites on an incoming plasmid, replacement occurs. This reaction is commonly defined as Recombinase- or Integrase-Mediated Cassette Exchange (RMCE or IMCE)9295 (Fig. 2C and 3C).

D. Advantages and Disadvantages

Since recombinases and integrases recognize very small sequence elements, they are ideal tools for genetic engineering14,96. However, these enzymes rely on the presence of their recognition sites, which must themselves be incorporated into the genome through transposition66,92,97103, P element transposon replacement (i.e., transposon backbone mediated gene conversion)104, or nuclease-catalyzed genome engineering105,106. Moreover, these target recognition sequences persist after the exchange reaction, potentially affecting the surrounding genome. Additionally, pseudo-sites, endogenous sequences with some homology to wild type recognition sites, have been identified for both enzyme families in eukaryotic genomes and can permit undesired recombination exchanges or integration events98,107,108. Finally, when expressed at high levels, recombinases62, and integrases86 can have detrimental off-target effects. Keeping these hurdles in mind, recombinases and integrases are highly useful reagents for genome engineering.

3.2 Nucleases

A variety of nucleases are used in the genome engineering field. These enzymes stimulate genome editing by cutting a designated nucleotide sequence and inducing DNA repair. Historically, transposases (i.e., enzymes that catalyze the mobilization of transposons from one location to another) initiated the field of targeted genome engineering at defined loci109111. However, transposases (e.g., P transposase) requires target sites to be “pre-activated” with a corresponding transposon insertion (i.e., P element in this case). Here, we focus on nucleases that do not rely on a transposon previously integrated at the intended cutting site. Currently, the most frequently used protein-guided nucleases include MegaNucleases (MNs)112, and Zinc Finger Nucleases (ZFNs) and Transcription Activator-Like Effector Nucleases (TALENs)48; while RNA-Guided Nucleases (RGNs) are conveniently guided by an RNA sequence113. Here we describe each of these nuclease families.

A. Meganucleases

Meganucleases, also known as homing nucleases, are rare-cutting endonucleases that recognize a 20–30 bp cognate recognition site (e.g., I-SceI and I-CreI recognize 18 bp and 22 bp target sites, respectively) (Fig. 4A). These sites are rare in eukaryotes, making MNs ideal candidates for targeted cutting of synthetic fragments introduced into these genomes114. Many MNs function as dimers with each monomer generating a single cut in complementary DNA strands, ultimately forming a Double Stranded Break (DSB)115. Although numerous MNs are available, I-SceI and I-CreI are the most frequently used for in vivo genome engineering in flies114,116.

Figure 4. DNA Nucleases.

Figure 4

A. The I-SceI meganuclease and recognition of its DNA target site. B. Zinc finger nucleases and DNA recognition through an array of stitched zinc fingers that each recognizes a unique DNA triplet. C. Transcription activator-like effector (TALE) nucleases and DNA recognition through an array of stitched TALE repeats that each recognize a unique single DNA base pair. D. RNA-guided nucleases and DNA recognition through base pairing of an RNA guide and its DNA target site. E. Nickases based on zinc finger binding domains (Left), TALE binding domains (Middle), and RNA guided nucleases (Right).

B. Zinc Finger Nucleases

A zinc finger (ZF) is a DNA-binding protein motif consisting of approximately 30 amino acids stabilized by a zinc ion. Each zinc finger binds to just three nucleotides, with different ZFs having higher affinities for certain DNA triplets117. A number of in vitro assembly methods have been developed to combine individual ZF motifs into ZF repeat arrays118. These arrays bind longer DNA sequences and can be customized to a specific target117 (Fig. 4B). Fusion of a ZF array to the catalytic domain of FokI results in an artificial restriction enzyme better known as a zinc finger nuclease119. As a type IIs restriction enzyme, FokI cuts DNA at a defined position outside of its recognition sequence120. FokI is an obligate dimer, necessitating that ZFNs be designed and implemented in pairs with each nuclease targeting one of the complementary DNA strands121. Although the usefulness of ZFNs has been extensively characterized in flies119,122128, they unfortunately failed to become fully adopted into the mainstream genetic toolbox by the Drosophila community.

C. Transcription Activator-Like Effector Nucleases

Similar to ZFNs, TALENs are hybrid proteins composed of a DNA-binding domain—in this case obtained from naturally occurring transcription factor family called Transcription Activator-Like Effectors (TALEs)—and the FokI nuclease domain129131, which converts TALEs into potent genome editors. The most commonly used TALE repeats are from Xanthomonas spp.132. A TALE contains a central DNA-binding domain consisting of a series of tandem repeats obtained from a natural TALE132. A single repeat motif is ~34 amino acids long, only two of which contribute to DNA binding sequence specificity133,134. Unlike the remainder of the repeat, these two amino acids are hypervariable and are thus termed the Repeat Variable Diresidues (RVDs). The four most common RVDs, NI (Asn-Ile), NN (Asn-Asn), NG (Asn-Gly) and HD (His-Asp), account for each of the four nucleotides (A, G, T, and C, respectively)135. These RVD-nucleotide associations are not exclusive, and most pairs can incorporate mismatches135. Nevertheless, multiple TALE repeats can be serially linked to form a synthetic DNA binding protein that recognizes up to two dozen nucleotides with high specificity135 (Fig. 4C). TALE domain repeats can be constructed using a number of modular assembly methods136, enabling construction of a custom TALE repeat protein in a matter of days129131. As with ZFNs, fusion of a TALE to the FokI nuclease domain requires TALENs be used in pairs129131, while fusion with a monomeric nuclease domain can negate this constraint137,138. Although TALENs have been adopted to gene editing paradigms within the Drosophila community106,123,139144, their use has been limited, most likely driven by the discovery of RGNs.

D. RNA-Guided Nucleases

The adaptive immune systems of eubacteria and archae, better known as CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats–CRISPR-ASsociated proteins) systems, have recently become highly attractive tools in for genome engineering113,145149. The simplest CRISPR-Cas, the Cas9 nuclease complex (e.g., from Streptomyces pyogenes), has been adapted to serve as an RGN, a highly versatile precision genome engineering tool. In contrast to ZFNs and TALENs that use a protein-nucleotide recognition code, Cas9 RGNs target the genome using a guide RNA molecule that contains 20 nucleotides complementary to the DNA sequence of interest150152 (Fig. 4D). In addition to RNA/DNA heteroduplex formation, Cas9 nuclease activity depends on the presence of a short Protospacer Adjacent Motif (PAM)153,154. The PAM must be located immediately downstream of the target DNA recognition sequence. In nature, bacteria use the PAM sequence, which is species-specific, to distinguish self from non-self. Cas9 RGNs contain two nuclease domains allowing them to cut both DNA strands and generate DSBs despite functioning as monomers151,154. RGN activity can be inactivated while maintaining DNA binding. Consequently, inactive RGNs can be fused to the catalytic domain of FokI, allowing them to function as dimers similar to ZFNs and TALENs155,156. The use of RGNs in nuclease-mediated applications has recently exploded, including in fruit flies for numerous gene editing paradigms157176.

E. Nuclease Reactions

All engineered DNA nucleases (i.e., MNs, ZFNs, TALENs, and RGNs) function in a similar manner: specificity elements direct nuclease function to a designated DNA target sequence that is subsequently cut and repaired. Previously, nuclease-induced DNA breaks were all described as DSBs, but nucleases can also be designed to generate single stranded DNA nicks (Fig. 4E). For example, ZFNs and TALENs function as obligate dimers and must be designed in pairs; however, inactivating the FokI catalytic domain in one half of the pair will induce a DNA nick at the target site rather than a DSB177180. Alternatively, ZFs and TALEs can be directly fused to a nickase instead of FokI, a strategy that was recently used to combine a TALE with the monomeric DNA mismatch repair endonuclease MutH181. Finally, the two nuclease activities of Cas9 RGNs can be independently inactivated to stimulate nicking on the DNA strand of choice151,152,182,183. The latter strategy was recently explored in flies170.

Once cut, there are two major pathways for DNA repair: Non-Homologous End Joining (NHEJ) and Homologous Recombination (HR)184 (Fig. 5A). DSBs can be repaired by either mechanism, while single stranded DNA nicks are usually repaired by HR. During NHEJ, cut strands religate, but ligation can be inaccurate, i.e., repetitive cutting followed by ligation will eventually select for NHEJ events that destroy the original cut site, resulting in formation of insertions or deletions (i.e., indels), unless the nuclease is titrated away by loss of expression, degradation or other means. Although the end products of NHEJ are unpredictable and intrinsically mutagenic often leading to the generation of knockout strains, this process should be avoided for precise genome engineering39. Conversely, HR uses a homologous DNA repair template to repair DSBs, making this process highly accurate185. Under normal cellular conditions the repair template is the endogenous homologous chromosome. However, the cellular machinery can be tricked into incorporating engineered sequences through a process called “gene targeting”, described below. Since NHEJ is more efficient than HR, several strategies have been developed to skew the balance toward HR. This can conveniently be accomplished by interfering with genes involved in the NHEJ pathway (e.g., Ligase4), through mutation (i.e., Lig4 is located on the X chromosome)126,127,176 or knockdown of the Lig4 transcript by RNAi or shRNAi159.

Figure 5. Repair Mechanisms and Homology Configuration.

Figure 5

A. DNA repair mechanisms after a double stranded cut. Non-homologous end joining (Left), and homologous recombination using an oligonucleotide (Middle) or double stranded DNA fragment (Right) are indicated. B. Homology configuration of a double stranded DNA template during homologous recombination. Ends-in (i.e., insertional) and ends-out (i.e., replacement) gene targeting are illustrated.

F. Gene Targeting and Exogenous Templates

Gene targeting is the modification of an endogenous genomic sequence through HR with an exogenous DNA fragment rather than its homologous chromosomal counterpart. This technique has been widely used in various multicellular model organisms and can be exploited to generate precise genetic modifications, including deletions, targeted insertions, and point mutations39,139. The exogenous targeting template can take many forms (e.g., oligonucleotides, PCR fragments, in vitro-prepared circular and linearized plasmids, or in vivo-generated targeting donors) as long as some homology with the intended DNA target is present (Fig. 5A). Oligonucleotides have been used with ZFNs, TALENS, and RGNs to generate targeted point mutations105,167,186,187, deletions157, or insertions105,162,163,167,188,189. PCR fragments159,164, and in vitro-prepared circular plasmids124,125,127,140,161,169,175 have also been combined with TALENs and/or RGNs to generate insertions140,159,161,169,175, deletions124,164,175, and point mutations125,175. Interestingly, in vitro-linearized plasmid donors, almost exclusively used in mouse ES cell gene targeting190, do not work in flies, at least using ZFN124, while targeting donors generated in vivo have been successfully used exclusively by D. melanogaster researchers for the same purposes114,160.

Experimental gene targeting occurs in one of two ways: as insertional gene targeting (i.e., ends-in targeting)191194 or as replacement gene targeting (i.e., ends-out targeting)191,195 (Fig. 5B). Ends-in and ends-out refer to the arrangement of the targeting template during HR. Ends-in gene targeting results in site-directed insertion of the entire targeting vector by a not yet fully understood mechanism that depends on vector linearization192,193. The outcome of an ends-in event is a localized tandem duplication of the targeted region. This duplication is often resolved by nuclease-mediated cutting (i.e., using I-CreI) within the integrated fragment, followed by tandem repeat reduction through HR194. Conversely, ends-out gene targeting occurs as a synthesis-dependent strand annealing event between homology arms present in the targeting template (e.g., a gene deletion construct) and the target DNA sequence126,196198. Ends-out targeting thus results in substitution of endogenous material with exogenous DNA195, including the introduction of additional sequences for screening or selection markers as part of the targeting template90,114,140,159,163,164,167,169,199,200.

G. Advantages and Disadvantages of Nucleases

Each nuclease has its own advantages and disadvantages. Meganuclease recognition sites are not common in eukaryotes, requiring their introduction into the genome prior to enzyme use115,201. This property makes MNs very useful for in vivo linearization of gene targeting constructs as illustrated extensively for D. melanogaster114. A big advantage of ZFNs, TALENs, and RGNs is that they are programmable, i.e., their action is targeted to sites determined by the researcher48. A primary drawback of ZFNs is the time needed to identify optimal repeat domains for superior target sequence affinity and specificity118. Constructing and validating TALEN assemblies can also be problematic due to their size and repetitive nature135. Fortunately, recoding of existing amino acid sequences using gene synthesis can ameliorate this issue202. Alternatively, TALE-like containing domains that are not perfect direct repeats have been discovered that should facilitate assembly of multi-repeat containing nucleases203205. Finally, both ZFN and TALEN strategies require that two new proteins be designed and generated for each target sequence118,135. In comparison, RGNs, which rely on simple RNA synthesis making them convenient tools to simultaneously target multiple independent loci (i.e., multiplex genome engineering)150,152. Multiplex genome engineering up to 4 independent loci was recently demonstrated to work in flies162,169. However, unlike ZFNs and TALENs, the function of RGNs is somewhat restricted by the presence of a PAM sequence (e.g., Streptomyces pyogenes PAM is NGG)113. This hurdle could be overcome by combining Cas9 systems from different bacterial species, each recognizing orthogonal PAM sequences, e.g., Streptococcus thermophiles153,154,206, Neisseria meningitides153, Treponema denticola153,207 and Staphylococcus aureus206,208, or generating mutant versions of S. pyogenes’ Cas9 that recognize orthogonal PAM sequences as well206.

Off-target events are a major concern for all programmable nucleases209211. Bioinformatic analysis can identify sites most likely to suffer from off-target events212215. Such reactions can be functionally validated by mismatch analysis (e.g., Surveyor nuclease test)216 or next generation sequencing210,214, thus helping researchers choose the best possible sequence to target for genome engineering. Alternatively, off-target sites can be physically captured using genome-wide, unbiased identification of DSBs enabled by sequencing (i.e., GUIDE-seq)217.

4. Practical Aspects of Genome Engineering

To produce heritable changes, genome engineering must occur during early development, prior to germ cell formation or directly within the germ line precursors. In flies, this can be achieved through three experimental approaches. First, editing tools are physically introduced via embryo transformation by microinjection, requiring outcrossing to ensure germ line transmission and identify unique events. Alternatively, in vivo remobilization allows gene targeting of complicated gene targeting constructs. Finally, in vivo upgrading allows novel material to be incorporated into previously established “docking” sites. The latter two paradigms are performed through genetic crosses conveniently circumventing any physical manipulation.

4.1 Genome Engineering by Embryo Microinjection

The first step for any kind of genome engineering introduced into flies is always embryo microinjection218,219. Under this paradigm, fertilized embryos are injected at a very specific developmental stage, the multinucleated syncytial one cell stage, just before cellularization. This timing maximizes the number of germ cells to be transformed before cellular membranes omit accessibility to the injected material218,219 (Fig. 6A). Injected animals must be outcrossed to identify germ line transmission of the engineered changes to the next generation. This strategy has been successful for many germ line-based manipulations in insects219.

Figure 6. Experimental Genome Engineering.

Figure 6

A. Syncytial microinjection performed during early embryonic stages in the fly D. melanogaster. B. In vivo remobilization during a classical gene targeting experiment in the fly D. melanogaster. F, FRT site; LA, left homology arm; RA, right homology arm. C. In vivo upgrading of transposon insertion sites using the InSITE system in the fly D. melanogaster. L, LoxP site.

Microinjection are generally done as “co-injection” or “direct” injections. During “co-injection” microinjection, two components are introduded: template, i.e., oligonucleotide, PCR fragment, circular or linearized plasmid, and catalyst, i.e., recombinase, integrase, or nuclease with or without guide RNA. The catalyst can be provided in trans, as plasmid DNA encoding a promoter driving the catalyst, i.e., ΦC31 integrase220, Cre recombinase66, Flp recombinase99, TALEN140, or Cas9105,162,163,174. Such plasmids are commonly known as “helper” plasmids219. Alternatively, mRNA encoding the catalyst can be injected, i.e., ΦC31 integrase92,98,103,221, Bxb1 integrase90, ZFN124,222, TALEN106,123,141,143,144,175, or RGN157,158,175. Finally, purified protein could be injected, e.g., Cas9166, but this is rarely performed. Co-injections limit catalyst activity over time (i.e., through dilution), which is often advantageous219. Alternative to co-injections, expression of the catalyst from a genomic source, i.e., “direct” injections, can be accomplished by injecting a genome engineering template without a helper plasmid; this requires that the catalyst (enzyme coding sequence) must have been established in the genome first before any genome engineering experiment can be performed97,164,165,167,168,171. So far, “direct” injections have been done for ΦC31 integrase97, ZFN119,122,125, and the Cas9 RGN164,165,167,168,171. While this approach simplifies the procedure tremendously, care must be taken to remove the catalyst-bearing chromosome by genetic outcrossing219.

Catalyst expression using helper plasmids or genomic sources can be driven by a variety of promoters. Constitutive expression can be achieved by using a CMV174, Copia140, or Act5C167 promoter. Temporal control can be achieved by using an inducible promoter, e.g., Hsp70 heat-shock promoter65,105,119,122,125,162,163,223. Alternatively, expression can be restricted spatially or regulated by normal endogenous physiology by using promoters from the germline-specific genes vasa97,164,171,173 and nanos97,165,168, directing expression in the embryonic germ cell precursors (i.e., pole cells), or the cystoblast-specific gene bag of marbles160, directing expression in ovarian germline stem cell progenitors (i.e., cystoblasts). Guide RNAs required for RGN function can be delivered as purified RNA species175,186 or can be expressed from helper plasmids driven by U6 small RNA expressing promoters (i.e., RNA polymerase III promoters directing U6-1, U6-2, U6-3 smRNAs)105,162,163,167,168, with the U6:3 promoter being optimal167. Interestingly, Cas9 and gRNA can be expressed from a single bicistronic helper plasmid, which simplifies injection procedures tremendously162.

4.2 In Vivo Remobilization of Gene Targeting Templates

Facing an inability to directly transform embryos with linearized targeting fragments (i.e., as performed in mouse embryonic stem cells)190, an alternative approach for precision genome engineering in flies was developed192,195. This new strategy uses crossing schemes to remobilize previously introduced transgenesis constructs from one “donor” location to the desired target locus, also known as the “acceptor” location191. In this paradigm, a gene targeting template containing one or two internal MN sites is flanked by two directly-oriented recombinase recognition sites. The targeting fragment is integrated into the genome via either transposase-191, or ΦC31 integrase-mediated transgenesis224,225 and subsequently recircularized out of the genome in the presence of an inducible recombinase (i.e., FLP)192,195. The circularized template is then linearized with an inducible MN (i.e., I-SceI) to generate reactive DSBs and trigger endogenous DNA repair. Placement of the MN recognition site(s) determines whether ends-in192,193 or ends-out195 targeting events will occur. A single cut in the middle of the homology region produces ends-in gene targeting and a tandem duplication of the region of interest192. This duplication can be resolved to a single copy through tandem repeat reduction with a second nuclease (i.e., I-CreI)194. Two cut sites outside the region of homology produce an exchange event through ends-out gene targeting, a much more commonly used experimental scenario160,195 (Fig. 6B). Gene targeting through in vivo remobilization has been used extensively in the D. melanogaster community114,199,200,226 and can be expanded by including ZFN-122 or RGN-mediated cutting at the target locus160. Recently, this method was extensively improved through the inclusion of cystoblast targeted expression of catalysts (i.e., Flp, I-SceI, and Cas9)160.

4.3 In Vivo Upgrading of Large Loci Collections

Due to some difficulties associated with in vivo remobilization-mediated gene targeting, several innovative methods were developed. The first uses FLP recombinase, resulting in remobilization of a transgene from its initial insertion site to a second FRT-containing site227. Successful events are easily identified by phenotypic screening since many transgenes contain the dominant eye color marker white+, which has varied expression in response to position effects219. Because the bidirectional nature of the FLP recombinase reaction may immediately excise the novel integration event, a second innovative method was developed using the unidirectional ΦC31 integrase, Integrase Swappable In vivo Targeting Element (InSITE)220 (Fig. 6C). Using highly efficient in vivo manipulation (i.e., FLP excises the donor and ΦC31 integrates it at the acceptor location), InSITE can simultaneously upgrade large collections of acceptor elements and is particularly attractive for its ability to easily incorporate future genetic tools. More recently, a derivative of InSITE, “Trojan exons”, was established to adapt a large collection of characterized MiMIC insertions towards gene-specific expression of binary activators228230. “Trojan exons” was subsequently adapted towards endogenous protein tagging231. The InSITE and “Trojan exons” approaches still require a large collection of characterized custom insertion loci to be generated, necessitating a substantial upfront workload229231.

5. Genome Engineering Paradigms

Precision genome engineering can occur on many levels. Individual genes may be targeted with small modifications such as a single nucleotide exchange, microdeletion, or tag insertion. Larger fragments containing regulatory elements (e.g., enhancers, silencers, and insulators) may be targeted with similar modifications232, or even orthologous sequence exchange, a method to detect evolutionary conservation of gene regulation across species233236. Manipulation of larger chromosomal segments can be used to study the effect of chromosomal rearrangements237239. Additionally, precision genome engineering is not restricted to manipulation of endogenous loci. Defined introduction of exogenous material can also be achieved through site-specific transgenesis219. While the bulk of engineering protocols focus on targeted manipulation of the nuclear genome, mitochondrial DNA can also be modified, though current engineering paradigms are fairly limited810.

5.1 Localized Genome Engineering

Localized genome engineering is the small scale manipulation of DNA at the “gene” level. Experiments target a single open reading frame or a localized feature within its vicinity (Fig. 7). These modifications include deletions (e.g., full or partial gene deletions)124,157,175,240,241, null or conditional alleles61,242, point mutations (i.e., hypomorphic-, null-, or disease-causing mutations)105,167,175,186,187,243246, substitutions (i.e., replacing one gene with its paralog, or genomic portion with its cDNA counterpart)240,241,247, or tagged genes (e.g., using peptides tags, fluorescent protein tags, or cellular localization signals)175,229,230,247251. Reporter alleles can also be generated, allowing endogenous gene expression patterns to be documented directly via a colorimetric marker (e.g., predominantly β-galactosidase activity in mice)252, or indirectly via a binary activation system (e.g., GAL4/UAS, QF/QUAS, and LexA/LexO)220,224,225,228,253255. Gene-specific alleles have been incorporated using many experimental approaches including microinjection218,219, in vivo remobilization114,200,226, and in vivo upgrading220,228.

Figure 7. Examples of Localized Genome Engineering.

Figure 7

Different alleles, their constitution and applications are indicated and compared to a WT “control” allele.

5.2 Chromosomal Exchanges and Syntenic Replacements

Occasionally, replacement of an entire locus is desired, i.e., the open reading frame plus its adjacent regulatory elements (Fig. 8A). Such substitutions can be easily achieved in flies using Captured Segment Exchange (CSE)232,256 (Fig. 8B). CSE allows exchange of a large genomic segment located between FLP recombinase and/or ΦC31 integrase recognition sites, with a new sequence that was manipulated in bacterial cells. Given the abundance of FLP and ΦC31 recognition sites throughout the fly genome229,230,257,258, CSE can be used to explore gene functions for most of the fly genome. Although only used to replace one version of the teashirt gene with mutated ones so far, CSE could be used to perform syntenic replacements, i.e., the exchange of presumably functionally orthologous DNA from other organisms233236. These replacements may provide evidence of evolutionary conservation between species234 or permit functional resurrection of genetic material extracted from preserved tissue samples259,260. Although current syntenic applications are biased toward humanization233,235,236, opportunities exist to perform general “species-zation” within the fly community; 12 Drosophila species have been sequenced and can be used for genetic fragment exchange to demonstrate the presence or absence of evolutionary conservation261,262. The availability of fosmid84,261,263265 and Bacterial Artificial Chromosome (BAC) libraries85,266269 covering most of the genomes of these species should facilitate these endeavors.

Figure 8. Chromosomal Exchange and Syntenic Replacement.

Figure 8

A. The principle of chromosomal exchange and syntenic replacement. B. Use of captured segment exchange to replace a chromosomal region in the fly D. melanogaster. R, recombinase recognition site.

5.3 Genome Engineering of Chromosomal Rearrangements

The manipulation of large chromosomal sections can be used to generate sizable chromosomal rearrangements, forming deletions, duplications, inversions and translocations. Chromosomal rearrangements can be engineered using site-specific recombination or gene targeting.

A. Deletions

Deletions, also known as deficiencies or excisions, are chromosomal rearrangements in which a substantial chromosome section is missing238. Because a deletion involves loss of genetic material, these rearrangements represent true null alleles for genes within the deleted fragment. Hence, they can be ideal “loss of function” control alleles for other mutations whose phenotypic nature is unclear or ambiguous.

There are two strategies to generate precise deletions in multicellular eukaryotes: site-specific recombination239 and HR270 (Fig. 9A). Site-specific recombination is more widely used and results in the deletion of genetic material located between two recognition sites (e.g., FRT) oriented in a direct fashion. These recognition sites can be located in cis on the same chromosome, or in trans on sister chromatids239. The site-specific FLP/FRT recombination system has been used extensively in flies and is the basis of a deletion collection that provides almost full (~98%) genome-wide coverage238,257,271,272. Currently, all deletions in this collection have been generated by bringing together two independent FRT-containing transposon insertion sites in trans and inducing recombination in vivo via the FLP recombinase. In addition to providing deficiencies for nearly the entire fly genome, this resource is an efficient and inexpensive way to determine the genetic location of unmapped lethal mutations by absence of complementation238.

Figure 9. Chromosomal Rearrangements.

Figure 9

A. Generation of a deletion using recombination sites located in cis. B. Generation of a reciprocal deletion and duplication using recombination sites located in trans. C. Generation of an inversion using recombination sites located in cis. Such inversions can be similarly generated using shared homology instead. D. Generation of an engineered balancer chromosome using recombination sites located in cis. Reconstitution of 5’- and 3’-parts of a marker results in visualization of the inversion event. E. Generation of a translocation between two non-homologous chromosomes using recombination sites located in trans. Such translocation can be similarly generated using shared homology instead. F. Generation of a translocation between two homologous chromosomes using recombination sites located in trans during mitotic recombination. This experimental paradigm can be further developed to include strategies for clonal marking, i.e., here the Mosaic Analysis with a Repressible Cell Marker (MARCM) is illustrated (Lee and Luo, 1999).

Deletions can also be generated by ends-out gene targeting273 and a derivative of ends-in gene targeting has been used to generate a gene deletion using HR270. Unlike ends-out targeting, ends-in targeting does not leave exogenous sequence at the target locus. Nuclease-based engineering can also generate precise deletions274,275. Such deletions require the generation of two DSBs followed by NHEJ between the two DSBs275, or gene conversion using a homologous template encompassing the intended deletion274. However, although HR was proven in cell culture, these methods have not been adapted to fruit flies yet.

B. Duplications

Chromosomal duplications are a major mechanism of generating new genetic material during molecular evolution276,277. In the laboratory, duplications are ideal experimental reagents that can be used as “rescue” fragments by complementing null or hypomorphic alleles of the same gene86,237.

To date, duplications have only been engineered using site-specific recombinases (Fig. 9B)239,271. Conveniently, they can be recovered as the reciprocal chromosomal rearrangement of deletions generated via site-specific recombination between two target recognition sequences located in trans. Precise duplications have been generated in D. melanogaster using the FLP/FRT recombination system239,271. Similar to deletions, duplications are expected to easily combine with nuclease strategies resulting in recombination sites at target loci in the genome followed by inter-chromosomal recombination.

C. Inversions and Engineered Balancer Chromosomes

An inversion is yet another rearrangement, one in which a chromosome segment is reversed end to end. Inversions occur when a single chromosome undergoes breakage and rearrangement within itself. An inversion does not typically involve loss of genetic information but merely rearranges the linear gene sequence. Hence, inversions only produce phenotypic effects when DNA break points are located within genes or other important genetically encoded features, e.g., disrupting interactions between enhancer and promoter fragments277. Lowered fertility can be observed in individuals with a heterozygous inversion due to formation of abnormal germ cells, which result from recombination events between inverted and non-inverted chromatids.

A specialized inversion event uniquely seen in experimental biology is the balancer chromosome. Balancer chromosomes were first developed using imprecise strategies (i.e., irradiation) in D. melanogaster, and are invaluable genetic reagents278. Balancer chromosomes contain three critical features: (i) inversions that eliminate the propagation of meiotic recombination events, (ii) recessive lethal (or sterile) mutations that affect reproductive viability or fitness of homozygous animals, and (iii) a dominant marker that can be followed from one generation to another in heterozygotes278. These three features allow populations of flies carrying heterozygous mutations to be stably maintained without the need for constant screening278.

Precise inversions can be generated using site-specific recombination systems with recombinase recognition sites located in cis (Fig. 9C). This technique has produced defined inversions in D. melanogaster via FLP/FRT239. Interestingly, a recombinase strategy (i.e., Cre/LoxP) has been used to generate balancer chromosomes in mice279281 (Fig. 9D). As described above for flies, these balancer chromosomes contain inversions as well as two engineered recessive lethal mutations and a dominant coat color marker. A similar genome engineering paradigm might be used to generate balancer chromosomes for unbalanced regions of the fly genome, or novel versions incorporating innovative features.

Precise inversions can additionally be generated by nuclease strategies but require some degree of homology at the cut sites. Consequently, such rearrangements have thus far only been created using a MN (e.g., I-SceI), which generated DSBs in two cis transposons, both containing an MN target recognition site and sharing homologous sequences65. In the absence of homology, nuclease-induced inversions catalyzed by TALENs and RGNs might be used but will contain indels as a result of NHEJ fusion of DSBs275.

D. Translocations and Mitotic Recombination

Classic chromosome translocations result from sequence exchange between non-homologous chromosomes282,283. Such translocations can be balanced (exchange occurs without loss or gain of information), or unbalanced (exchange results in deleted or duplicated genes). A translocation that occurs between two otherwise separate loci may produce abnormal gene fusions. Such catastrophic fusions are common in certain cancers282.

As with other chromosomal rearrangements, precise translocations have only been generated using site-site-specific recombination239 (Fig. 9E). Precise translocations require recombinase recognition sites that are located in trans, and have been created in D. melanogaster using FLP/FRT239. Nuclease strategies can also be used to generate precise translocations. However, as with inversions, the DSBs necessary for rearrangement have until now only occurred in transposons, exploiting their shared homology to prevent NHEJ and indel formation65. Programmable nucleases have been used to generate precise translocations, but only through NHEJ284286. Such strategies remain to be explored in flies.

Specialized translocations can also occur between homologous chromosomes as a result of mitotic recombination. If a cell is heterozygous for a given gene mutation, mitotic recombination permits two genetically distinct daughter cells to be created following cell division—one cell will be homozygous wild type and one will be homozygous mutant. This phenomenon has been exploited in D. melanogaster using the FLP/FRT recombinase system in a technique known as mitotic analysis287 (Fig. 9F). In this paradigm, controlled FLP expression induces recombination between centromeric FRT sites on homologous chromosomes. Any genes located distal to the FRT site are exchanged as part of this reaction. Hence, tissue- or temporal-specific recombinase expression results in homozygous mutant cells in an otherwise heterozygous animal. By incorporating sophisticated genetic gadgets, this technology allows differential labeling of both daughter cells and their descendants, which has been extensively illustrated in flies288292. Currently, genes are located between the available FRT sites and the centromere cannot be interrogated with this technology. Hence, extra effort will be required to generate novel FRT sites that are located as proximal as possible to the centromere, relative to the known genome sequence38.

5.4 Precise Genomic Transgene Addition

Genome engineering also includes the addition of ectopic material to the fly genome219. For precise engineering these sequences must be introduced by site-specific integration to avoid unwanted gene disruption, multi-insertion events, and position effect variegation; a phenomenon in which transgene expression varies due to differences in the surrounding genomic environment219. Site-specific integration is most easily achieved through integrase-based paradigms or nuclease-mediated transgene targeting since both of these methods produce stable integration events219,293. Integrase-based methods rely on the previous introduction of “docking” or “landing” sites into benign genomic locations that contain an appropriate attP recognition sequence allowing subsequent site-specific integration of transgenes containing attB-sites219. Integration can be achieved using “typical” single site-specific transgenesis, which is the more common method involving a single pair of integrase recognition sites97,98,100,102,103,294 (Fig.10A), or by using two pairs of integrase recognition sites, better known as IMCE92,232 (Fig. 10B). Two pairs of orthogonally acting recombination sites may also be used, resulting in RMCE66,99 (Fig. 10C).

Figure 10. Site-Specific Transgenesis.

Figure 10

A. Site-specific integration using the ΦC31 integrase and a single set of attachment sites. MCS, multiple cloning site. B. Site-specific integration using the ΦC31 integrase and a double set of attachment sites resulting in integrase-mediated cassette exchange (IMCE). Integration can occur bidirectionally (i.e., in both orientations). C. Bidirectional recombinase-mediated cassette exchange (RMCE) using orthogonal LoxP or FRT sites.

Site-specific transgenesis can be done using both small and large plasmids. Small plasmids typically encompass expression modules (i.e., RNAi or open reading frames encoding endogenous cDNA or fluorescent markers), or small genomic fragments. Such plasmids can be easily generated and modified by in vitro cloning methods83,8789,97,295,296. Conversely, large plasmids often include extensive genomic fragments8486,103. Genome-wide transgene coverage for site-specific integration can be generated as genomic DNA libraries using fosmids or BACs as plasmid backbones84,85. The transgene vector size limit of fosmids is ~48 kb, defined by phage packaging constraints84, while the insert limit of BACs is primarily defined by limitations of DNA isolation and stability of the DNA insert in E. coli85,266. Genomic DNA libraries covering most of the genome are available for several fly species and other insects (https://bacpac.chori.org/)84,85,261,263269. DNA libraries can be upgraded with elements required for site-specific transgenesis by plasmid retrofitting of fosmids and BACs103,264, or they can be generated in a plasmid backbone that is fully transgenesis compatible84,85. Moreover, recombineering technology allows easy modification of fosmid and BAC plasmids, allowing incorporation of deletions, protein tags, gene tags, as well as point mutations15,84,85,297.

Integrase strategies for targeted integration of large transgenes were pioneered in D. melanogaster using the ΦC31 integrase97,98. Interestingly, ΦC31 integrase-mediated site-specific integration can integrate very large fragments (i.e., 146 kb)85,86,103,298, even up to 220 kb (Unpublished data, KJTV), and has been used to generate a close to full BAC TransgeneOmic complement of two entire D. melanogaster chromosomes, the X chromosome86, and the 4th “dot” chromosome (Unpublished data, KJTV)299.

In contrast to integrase strategies, nuclease assisted site-specific integration is only in its infancy293. It would be attractive to combine both technologies by introducing attP sites in the genome using nuclease strategies followed by integration of very large DNA transgenes using integrase-directed site-specific integration.

5.5 Combining Gene Targeting and Transgene Addition

Due to the significant labor needed for successful gene targeting, several methods have been developed that combine an initial labor intensive gene targeting stage with a second relatively easy site-specific integration step. These methods have been primarily developed in D. melanogaster200,242,300303 and include Site-specific Integrase-mediated Repeated Targeting (SIRT)301, Integrase-Mediated Approach for Gene Knockout (IMAGO)242, RMCE303, Genomic Engineering (GE)200, and In Situ Integration for Repeated Targeting (InSIRT)302.

SIRT was developed to facilitate downstream modification following ends-in gene targeting301 (Fig.11A). In this method ends-in targeting introduces an attP site for ΦC31, which is then used to integrate novel engineered alleles contained within an attB plasmid, allowing limitless manipulation of the target locus for structure/function analysis301. A derivative of the method was used to perform long-range targeted manipulation by inserting a novel attP site 70 kb from the initial attP site, making 140 kb of the genome surrounding any existing attP site available for manipulation304. SIRT and its derivatives are fairly labor intensive. Similar methods were developed to generate novel engineered alleles after ends-out gene targeting. One such method, GE or InSIRT, is based on regular ΦC31-mediated transgenesis followed by Cre reduction200,300,302 (Fig. 11B). These methods are less labor intensive than SIRT but still require substantial work. Alternatively, IMAGO, likely the easiest method, is founded on ΦC31-catalyzed IMCE242,303,305 (Fig. 11C). A derivative of IMAGO uses existing MiMIC insertions to integrate targeting donors directly at the acceptor locus. After donor release with a MN (I-SceI and/or I-CreI), homologous recombination occurs at both sides of the transposon insertion site resulting in a targeted allele and cleanup of the original MiMIC transposon insertion251. Integrase-based engineering has also expanded to include the Bxb1 enzyme for subsequent genome manipulations90. These combined gene targeting/recombinase/integrase strategies have allowed the creation of knock-in90,242,300 and conditional knockout alleles61,242, small deletions200,302, point mutations200,300, deletions251, and insertions200,248,251,300. Each of these strategies can easily take advantage of the current nuclease revolution. Nuclease strategies can be used to integrate attP sites using gene targeting, followed by targeted insertion of modified transgenic constructs61,176,306.

Figure 11. Combination Engineering.

Figure 11

A. Site-specific Integrase-mediated Repeated Targeting (SIRT) in the fly D. melanogaster. MA, middle homology arm. B. Genomic engineering (GE)/In situ integration for repeated targeting (InSIRT) in D. melanogaster. C. Integrase-mediated cassette exchange (IMCE)/Integrase-mediated approach for gene knockout (IMAGO) used in D. melanogaster.

5.6 Organelle Engineering

A specialized form of precision genome engineering in animal models involves the modification of mitochondrial DNA. Mitochondrial genomes are often less than 20kb in length, yet their mutations can contribute to cellular dysfunction and disease307. Until recently high copy number, random segregation, and heteroplasmy (i.e., variation in the DNA sequence of different mitochondria in the same cell or organism) confounded genetic analysis of these genomes. Moreover, experiments involving mitochondrial DNA editing are constrained due to two technical challenges: the lack of DNA repair pathways in mitochondria that are naturally present in the nucleus (i.e., NHEJ and HR), and difficulties of delivering repair templates to that organelle. Nonetheless, researchers have been able to manipulate organellar DNA by targeting Type II restriction enzymes (e.g., XhoI) specifically to the mitochondria through addition of mitochondrial signal sequences10. Similarly, programmable nucleases (e.g., TALENs) have been targeted to mitochondria as well308, but this strategy has yet to be applied in vivo. However, due to the absence of repair pathways, targeted cutting results in depletion and not repair of the targeted unwanted genome10,308. Additionally, recombinase- and integrase-based manipulations also have yet to be developed for the mitochondrial genome, although they have been extensively applied to chloroplasts, a plant-specific organelle that also has its own DNA309. Hence, numerous opportunities exist to devise ingenious ways to manipulate the mitochondrial genome.

6. Future Directions

Detailed genomic sequence annotation is available for most classical model systems (e.g., D. melanogaster)37,38. Using a plethora of in vitro and in vivo phenotypic screening paradigms, establishing the functional relevance of each of their genes is now within reach. Moreover, genomic sequences of many other insects are currently available310313, and the speed with which additional species are sequenced increases daily. Thus, the ability to design and conduct experiments that interrogate the genome at virtually any level in any organism is on the horizon. Indeed, any sequenced species can now be repurposed as a genetically-modifiable model system314,315. Researchers can therefore select the organism best-suited to study their particular biological question of interest rather than relying on more traditional models. Nonetheless, the availability of well-established model organisms (e.g., D. melanogaster) allows sophisticated genome engineering paradigms to be established that then can be easily extrapolated to more exotic choices.

For classic model organisms, extrapolation of a given method can quickly result in substantial resource collections that are generally geared toward one application. Even when upgrading capabilities are incorporated into the “master” allele collection, the location of the insertion site is defined by experimental system (e.g., transposon jumping)220,230, or experimenter’s choice (e.g., Cas9 guided insertion)61,176,228, and therefore not customizable unless a new integration event is generated. Although such collections may rapidly advance scientific progress by allowing genome-wide interrogation for specific biological phenomena, these genome-wide reagent collections must be easily accessible to every lab. In reality such access is often problematic. The maintenance of, and accessibility to, such collections, especially genome-wide in vivo libraries, is nearly impossible. Moreover, generation of novel tools is currently so fast paced that by the time a genome-wide in vivo collection has been generated, the tool has already been improved, replaced or even challenged316,317, even when “upgrading” capabilities are included220,230. Hence, current trends in technology evolution should perhaps shift toward increasing the efficiency of rapid and easy dissemination of highly specialized methods using detailed protocol papers (e.g., Nature Protocols, www.nature.com/nprot/), video articles (e.g., Journal of Visualized Experiments, http://www.jove.com/), specialized knowledge distribution networks (e.g., Insect Genetic Technologies Research Coordination Network, http://igtrcn.org/), or other means. Access to specialized methodology using the least expensive hardware would facilitate the generation of precisely customized alleles in any research lab, enabling highly specific experimental paradigms. Consequently, the scientific community would shift away from large in vivo genome-wide libraries that are generated for a custom purpose. Public repositories could then focus on maintaining and distributing a large variety of novel highly flexible reagent tools rather than the very few, often highly customized, in vivo collections that currently dominate such repositories.

7. Conclusions

We have summarized the most common tools and methods used for genome engineering in fruit flies. Recombinases and integrases allow researchers to generate virtually any chromosomal rearrangement. Currently numerous recombinases and integrases allow ever more sophisticated experimental paradigms to be designed. Although recombination recognition sequences are traditionally introduced by random transposition or laborious gene targeting paradigms, they can now be placed virtually anywhere using easily programmable nucleases. Moreover, RGNs allow researchers to incorporate multiple genome changes at once, i.e., in a multiplex fashion. Finally, nucleases also allow researchers to generate precisely engineered alleles through gene targeting using constructs with homology arms, PCR fragments, or even oligonucleotides. Since many of the paradigms discussed in this overview are still in the early stages of development, most if not all will be improved over time. We are witnessing a technological revolution at several levels that will not only facilitate biological research in fruit flies, but can also be extrapolated to other existing and emerging insect model organisms. Perhaps within the near future, we will witness the experimental manipulation of entire chromosomes and genomes of a multicellular eukaryotic organism. Let’s keep our fingers crossed this will be the fruit fly Drosophila melanogaster.

Acknowledgements

We apologize to those whose work we did not cite due to focus and space limitations. The Venken team’s research is supported by startup funds kindly provided by Baylor College of Medicine, the Albert and Margaret Alkek Foundation, and the McNair Medical Institute, as well as grants from the March of Dimes Foundation (#1-FY14-315), the Cancer Prevention and Research Institute of Texas (R1313), and the National Institutes of Health (1R21HG006726, 1R21GM110190, and R01GM109938).

Abbreviations

attB

ATTachment site used by Bacteria

attL

ATTachment site at the Left

attP

ATTachment site used by Phage

attR

ATTachment site at the Right

BAC

Bacterial Artificial Chromosome

Cas

CRISPR-ASsociated proteins

Cre

Causes REcombination

CRISPR

Clustered Regularly Interspaced Short Palindromic Repeats

DSB

Double Stranded Break

FLP

FLiPpase

FRT

FLP recombinase Recognition Target

GE

Genomic Engineering

HR

Homologous Recombination

IMAGO

Integrase-Mediated Approach for Gene KnockOut

IMCE

Integrase-Mediated Cassette Exchange

InSIRT

IN Situ Integration for Repeated Targeting

InSITE

Integrase Swappable In vivo Targeting Element

LoxP

LOcus of crossing (X) over, P1

MARCM

Mosaic Analysis with a Repressible Cell Marker

MN

MegaNuclease

NHEJ

Non-Homologous End Joining

PAM

Protospacer Adjacent Motif

RGN

RNA-Guided Nuclease

RMCE

Recombinase-Mediated Cassette Exchange

RVD

Repeat Variable Diresidue

SIRT

Site-specific Integrase-mediated Repeated Targeting

TALE

Transcription Activator-Like Effector

TALEN

Transcription Activator-Like Effector Nuclease

ZF

Zinc Finger

ZFN

Zinc Finger Nuclease

References

  • 1.Esvelt KM, Wang HH. Genome-scale engineering for systems and synthetic biology. Mol Syst Biol. 2013;9(1744-4292 (Electronic)):641. doi: 10.1038/msb.2012.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Karas BJ, Suzuki Y, Weyman PD. Strategies for cloning and manipulating natural and synthetic chromosomes. Chromosome Res. 2015;23(1573-6849 (Electronic)):57–68. doi: 10.1007/s10577-014-9455-3. [DOI] [PubMed] [Google Scholar]
  • 3.Gibson DG, Benders GA, Andrews-Pfannkoch C, et al. Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome. Science. 2008;319(5867):1215–1220. doi: 10.1126/science.1151721. [DOI] [PubMed] [Google Scholar]
  • 4.Annaluru N, Muller H, Mitchell LA, et al. Total synthesis of a functional designer eukaryotic chromosome. Science. 2014;344(1095-9203 (Electronic)):55–58. doi: 10.1126/science.1249252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Dymond JS, Richardson SM, Coombes CE, et al. Synthetic chromosome arms function in yeast and generate phenotypic diversity by design. Nature. 2011;477(7365):471–476. doi: 10.1038/nature10403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Golic KG. RNA-guided nucleases: a new era for engineering the genomes of model and nonmodel organisms. Genetics. 2013;195(1943-2631 (Electronic)):303–308. doi: 10.1534/genetics.113.155093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Peng Y, Clark KJ, Campbell JM, Panetta MR, Guo Y, Ekker SC. Making designer mutants in model organisms. Development. 2014;141(1477-9129 (Electronic)):4042–4054. doi: 10.1242/dev.102186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bacman SR, Williams SL, Pinto M, Moraes CT. The use of mitochondria-targeted endonucleases to manipulate mtDNA. Methods Enzym. 2014;547(1557-7988 (Electronic)):373–397. doi: 10.1016/B978-0-12-801415-8.00018-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Reddy P, Ocampo A, Suzuki K, et al. Selective elimination of mitochondrial mutations in the germline by genome editing. Cell. 2015;161(1097-4172 (Electronic)):459–469. doi: 10.1016/j.cell.2015.03.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Xu H, DeLuca SZ, O’Farrell PH. Manipulating the metazoan mitochondrial genome with targeted restriction enzymes. Science. 2008;321(1095-9203 (Electronic)):575–577. doi: 10.1126/science.1160226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Boulin T, Hobert O. From genes to function: the C. elegans genetic toolbox. Wiley Interdiscip Rev Dev Biol. 2012;1(1759-7692 (Electronic)):114–137. doi: 10.1002/wdev.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Pandey UB, Nichols CD. Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol Rev. 2011;63(1521-0081 (Electronic)):411–436. doi: 10.1124/pr.110.003293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.St Johnston D. Using mutants, knockdowns, and transgenesis to investigate gene function in Drosophila. Wiley Interdiscip Rev Dev Biol. 2013;2(1759-7692 (Electronic)):587–613. doi: 10.1002/wdev.101. [DOI] [PubMed] [Google Scholar]
  • 14.Venken KJT, Bellen HJ. Genome-wide manipulations of Drosophila melanogaster with transposons, Flp recombinase, and ΦC31 integrase. Methods Mol Biol Clifton NJ. 2012;859:203–228. doi: 10.1007/978-1-61779-603-6_12. [DOI] [PubMed] [Google Scholar]
  • 15.Venken KJT, Bellen HJ. Chemical mutagens, transposons, and transgenes to interrogate gene function in Drosophila melanogaster. Methods San Diego Calif. 2014;68(1):15–28. doi: 10.1016/j.ymeth.2014.02.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Venken KJT, Simpson JH, Bellen HJ. Genetic manipulation of genes and cells in the nervous system of the fruit fly. Neuron. 2011;72(2):202–230. doi: 10.1016/j.neuron.2011.09.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Aida T, Imahashi R, Tanaka K. Translating human genetics into mouse: the impact of ultra-rapid in vivo genome editing. Dev Growth Differ. 2014;56(1440-169X (Electronic)):34–45. doi: 10.1111/dgd.12101. [DOI] [PubMed] [Google Scholar]
  • 18.Menke DB. Engineering subtle targeted mutations into the mouse genome. Genesis. 2013;51(1526-968X (Electronic)):605–618. doi: 10.1002/dvg.22422. [DOI] [PubMed] [Google Scholar]
  • 19.Huang G, Tong C, Kumbhani DS, Ashton C, Yan H, Ying QL. Beyond knockout rats: new insights into finer genome manipulation in rats. Cell Cycle. 2011;10(1551-4005 (Electronic)):1059–1066. doi: 10.4161/cc.10.7.15233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Mashimo T. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats. Dev Growth Differ. 2014;56(1440-169X (Electronic)):46–52. doi: 10.1111/dgd.12110. [DOI] [PubMed] [Google Scholar]
  • 21.Hisano Y, Ota S, Kawahara A. Genome editing using artificial site-specific nucleases in zebrafish. DevGrowth Differ. 2014;56(1440-169X (Electronic)):26–33. doi: 10.1111/dgd.12094. [DOI] [PubMed] [Google Scholar]
  • 22.Vacaru AM, Unlu G, Spitzner M, Mione M, Knapik EW, Sadler KC. In vivo cell biology in zebrafish - providing insights into vertebrate development and disease. J Cell Sci. 2014;127(1477-9137 (Electronic)):485–495. doi: 10.1242/jcs.140194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Lois C, Groves JO. Genetics in non-genetic model systems. Curr Opin Neurobiol. 2012;22(1873-6882 (Electronic)):79–85. doi: 10.1016/j.conb.2011.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hedges SB. The origin and evolution of model organisms. Nat Rev Genet. 2002;3(1471-0056 (Print)):838–849. doi: 10.1038/nrg929. [DOI] [PubMed] [Google Scholar]
  • 25.Lehner B. Genotype to phenotype: lessons from model organisms for human genetics. Nat Rev Genet. 2013;14(1471-0064 (Electronic)):168–178. doi: 10.1038/nrg3404. [DOI] [PubMed] [Google Scholar]
  • 26.Markaki M, Tavernarakis N. Modeling human diseases in Caenorhabditis elegans. Biotechnol J. 2010;5(1860-7314 (Electronic)):1261–1276. doi: 10.1002/biot.201000183. [DOI] [PubMed] [Google Scholar]
  • 27.Wangler MF, Yamamoto S, Bellen HJ. Fruit flies in biomedical research. Genetics. 2015;199(1943-2631 (Electronic)):639–653. doi: 10.1534/genetics.114.171785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bier E. Drosophila, the golden bug, emerges as a tool for human genetics. Nat Rev Genet. 2005;6(1471-0056 (Print)):9–23. doi: 10.1038/nrg1503. [DOI] [PubMed] [Google Scholar]
  • 29.Reiter LT, Potocki L, Chien S, Gribskov M, Bier E. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res. 2001;11(1088-9051 (Print)):1114–1125. doi: 10.1101/gr.169101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Molnar C, Lopez-Varea A, Hernandez R, de Celis JF. A gain-of-function screen identifying genes required for vein formation in the Drosophila melanogaster wing. Genetics. 2006;174(0016-6731 (Print)):1635–1659. doi: 10.1534/genetics.106.061283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Gonzalez C. Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics. Nat Rev Cancer. 2013;13(1474-1768 (Electronic)):172–183. doi: 10.1038/nrc3461. [DOI] [PubMed] [Google Scholar]
  • 32.Rudrapatna VA, Cagan RL, Das TK. Drosophila cancer models. Dev Dyn. 2012;241(1097-0177 (Electronic)):107–118. doi: 10.1002/dvdy.22771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(0092-8674 (Print)):57–70. doi: 10.1016/s0092-8674(00)81683-9. [DOI] [PubMed] [Google Scholar]
  • 34.Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(1097-4172 (Electronic)):646–674. doi: 10.1016/j.cell.2011.02.013. [DOI] [PubMed] [Google Scholar]
  • 35.Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell. 2009;136(1097-4172 (Electronic)):823–837. doi: 10.1016/j.cell.2009.02.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(1097-4172 (Electronic)):1194–1217. doi: 10.1016/j.cell.2013.05.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Adams MD, Celniker SE, Holt RA, et al. The genome sequence of Drosophila melanogaster. Science. 2000;287(0036-8075):2185–2195. doi: 10.1126/science.287.5461.2185. [DOI] [PubMed] [Google Scholar]
  • 38.Hoskins RA, Carlson JW, Wan KH, et al. The Release 6 reference sequence of the Drosophila melanogaster genome. Genome Res. 2015;25(1549-5469 (Electronic)):445–458. doi: 10.1101/gr.185579.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Carroll D. Genome engineering with targetable nucleases. Annu Rev Biochem. 2014;83(1545-4509 (Electronic)):409–439. doi: 10.1146/annurev-biochem-060713-035418. [DOI] [PubMed] [Google Scholar]
  • 40.Dar AC, Das TK, Shokat KM, Cagan RL. Chemical genetic discovery of targets and anti-targets for cancer polypharmacology. Nature. 2012;486(1476-4687 (Electronic)):80–84. doi: 10.1038/nature11127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Markstein M, Dettorre S, Cho J, Neumuller RA, Craig-Muller S, Perrimon N. Systematic screen of chemotherapeutics in Drosophila stem cell tumors. Proc Natl Acad Sci USA. 2014;111(1091-6490 (Electronic)):4530–4535. doi: 10.1073/pnas.1401160111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Lee T. Generating mosaics for lineage analysis in flies. Wiley Interdiscip Rev Dev Biol. 2014;3(1759-7692 (Electronic)):69–81. doi: 10.1002/wdev.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Rebollo E, Karkali K, Mangione F, Martin-Blanco E. Live imaging in Drosophila: The optical and genetic toolkits. Methods. 2014;68(1095-9130 (Electronic)):48–59. doi: 10.1016/j.ymeth.2014.04.021. [DOI] [PubMed] [Google Scholar]
  • 44.Gaj T, Sirk SJ, Barbas CF., III Expanding the scope of site-specific recombinases for genetic and metabolic engineering. Biotechnol Bioeng. 2014;111(1097-0290 (Electronic)):1–15. doi: 10.1002/bit.25096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Brown WR, Lee NC, Xu Z, Smith MC. Serine recombinases as tools for genome engineering. Methods. 2011;53(1095-9130 (Electronic)):372–379. doi: 10.1016/j.ymeth.2010.12.031. [DOI] [PubMed] [Google Scholar]
  • 46.Fogg PC, Colloms S, Rosser S, Stark M, Smith MC. New Applications for Phage Integrases. J Mol Biol. 2014;426(1089-8638 (Electronic)):2703–2716. doi: 10.1016/j.jmb.2014.05.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Xu Z, Thomas L, Davies B, Chalmers R, Smith M, Brown W. Accuracy and efficiency define Bxb1 integrase as the best of fifteen candidate serine recombinases for the integration of DNA into the human genome. BMC Biotechnol. 2013;13(1472-6750 (Electronic)):87. doi: 10.1186/1472-6750-13-87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Gaj T, Gersbach CA, Barbas CF., III ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 2013;31(1879-3096 (Electronic)):397–405. doi: 10.1016/j.tibtech.2013.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Kim H, Kim JS. A guide to genome engineering with programmable nucleases. Nat Rev Genet. 2014;15(1471-0064 (Electronic)):321–334. doi: 10.1038/nrg3686. [DOI] [PubMed] [Google Scholar]
  • 50.Bischof J, Basler K. Recombinases and their use in gene activation, gene inactivation, and transgenesis. Methods Mol Biol. 2008;420(1064-3745 (Print)):175–195. doi: 10.1007/978-1-59745-583-1_10. [DOI] [PubMed] [Google Scholar]
  • 51.Branda CS, Dymecki SM. Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev Cell. 2004;6(1534-5807):7–28. doi: 10.1016/s1534-5807(03)00399-x. [DOI] [PubMed] [Google Scholar]
  • 52.Albert H, Dale EC, Lee E, Ow DW. Site-specific integration of DNA into wild-type and mutant lox sites placed in the plant genome. Plant J. 1995;7(0960-7412):649–659. doi: 10.1046/j.1365-313x.1995.7040649.x. [DOI] [PubMed] [Google Scholar]
  • 53.Senecoff JF, Rossmeissl PJ, Cox MM. DNA recognition by the FLP recombinase of the yeast 2 mu plasmid. A mutational analysis of the FLP binding site. J Mol Biol. 1988;201(0022-2836 (Print)):405–421. doi: 10.1016/0022-2836(88)90147-7. [DOI] [PubMed] [Google Scholar]
  • 54.Langer SJ, Ghafoori AP, Byrd M, Leinwand L. A genetic screen identifies novel non-compatible loxP sites. Nucleic Acids Res. 2002;30(1362-4962):3067–3077. doi: 10.1093/nar/gkf421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Lee G, Saito I. Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination. Gene. 1998;216(0378-1119):55–65. doi: 10.1016/s0378-1119(98)00325-4. [DOI] [PubMed] [Google Scholar]
  • 56.Missirlis PI, Smailus DE, Holt RA. A high-throughput screen identifying sequence and promiscuity characteristics of the loxP spacer region in Cre-mediated recombination. BMC Genomics. 2006;7(1471-2164 (Electronic)):73. doi: 10.1186/1471-2164-7-73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Schlake T, Bode J. Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci. Biochemistry (Mosc) 1994;33(0006-2960 (Print)):12746–12751. doi: 10.1021/bi00209a003. [DOI] [PubMed] [Google Scholar]
  • 58.Sauer B. Multiplex Cre/lox recombination permits selective site-specific DNA targeting to both a natural and an engineered site in the yeast genome. Nucleic Acids Res. 1996;24(0305-1048):4608–4613. doi: 10.1093/nar/24.23.4608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Siegal ML, Hartl DL. Transgene Coplacement and high efficiency site-specific recombination with the Cre/loxP system in Drosophila. Genetics. 1996;144(0016-6731):715–726. doi: 10.1093/genetics/144.2.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Siegal ML, Hartl DL. Application of Cre/loxP in Drosophila. Site-specific recombination and transgene coplacement. Methods Mol Biol. 2000;136(1064-3745):487–495. doi: 10.1385/1-59259-065-9:487. [DOI] [PubMed] [Google Scholar]
  • 61.Frickenhaus M, Wagner M, Mallik M, Catinozzi M, Storkebaum E. Highly efficient cell-type-specific gene inactivation reveals a key function for the Drosophila FUS homolog cabeza in neurons. Sci Rep. 2015;5(2045-2322 (Electronic)):9107. doi: 10.1038/srep09107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Heidmann D, Lehner CF. Reduction of Cre recombinase toxicity in proliferating Drosophila cells by estrogen-dependent activity regulation. Dev Genes Evol. 2001;211(0949-944X):458–465. doi: 10.1007/s004270100167. [DOI] [PubMed] [Google Scholar]
  • 63.Nern A, Pfeiffer BD, Svoboda K, Rubin GM. Multiple new site-specific recombinases for use in manipulating animal genomes. Proc Natl Acad Sci USA. 2011;108(1091-6490 (Electronic)):14198–14203. doi: 10.1073/pnas.1111704108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Boulina M, Samarajeewa H, Baker JD, Kim MD, Chiba A. Live imaging of multicolor-labeled cells in Drosophila. Development. 2013;140(1477-9129 (Electronic)):1605–1613. doi: 10.1242/dev.088930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Egli D, Hafen E, Schaffner W. An efficient method to generate chromosomal rearrangements by targeted DNA double-strand breaks in Drosophila melanogaster. Genome Res. 2004;14(1088–9051):1382–1393. doi: 10.1101/gr.2279804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Oberstein A, Pare A, Kaplan L, Small S. Site-specific transgenesis by Cre-mediated recombination in Drosophila. Nat Methods. 2005;2(1548-7091 (Print)):583–585. doi: 10.1038/nmeth775. [DOI] [PubMed] [Google Scholar]
  • 67.Nakazawa N, Taniguchi K, Okumura T, Maeda R, Matsuno K. A novel Cre/loxP system for mosaic gene expression in the Drosophila embryo. Dev Dyn. 2012;241(1097-0177 (Electronic)):965–974. doi: 10.1002/dvdy.23784. [DOI] [PubMed] [Google Scholar]
  • 68.Anastassiadis K, Fu J, Patsch C, et al. Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice. Dis Model Mech. 2009;2(1754-8411 (Electronic)):508–515. doi: 10.1242/dmm.003087. [DOI] [PubMed] [Google Scholar]
  • 69.Sauer B, McDermott J. DNA recombination with a heterospecific Cre homolog identified from comparison of the pac-c1 regions of P1-related phages. Nucleic Acids Res. 2004;32(1362-4962 (Electronic)):6086–6095. doi: 10.1093/nar/gkh941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Karimova M, Abi-Ghanem J, Berger N, Surendranath V, Pisabarro MT, Buchholz F. Vika/vox, a novel efficient and specific Cre/loxP-like site-specific recombination system. Nucleic Acids Res. 2013;41(1362-4962 (Electronic)):e37. doi: 10.1093/nar/gks1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Minorikawa S, Nakayama M. Recombinase-mediated cassette exchange (RMCE) and BAC engineering via VCre/VloxP and SCre/SloxP systems. Biotechniques. 2011;50(1940-9818 (Electronic)):235–246. doi: 10.2144/000113649. [DOI] [PubMed] [Google Scholar]
  • 72.Suzuki E, Nakayama M. VCre/VloxP and SCre/SloxP: new site-specific recombination systems for genome engineering. Nucleic Acids Res. 2011;39(1362-4962 (Electronic)):e49. doi: 10.1093/nar/gkq1280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Buchholz F, Stewart AF. Alteration of Cre recombinase site specificity by substrate-linked protein evolution. Nat Biotechnol. 2001;19(1087-0156 (Print)):1047–1052. doi: 10.1038/nbt1101-1047. [DOI] [PubMed] [Google Scholar]
  • 74.Sarkar I, Hauber I, Hauber J, Buchholz F. HIV-1 proviral DNA excision using an evolved recombinase. Science. 2007;316(1095-9203 (Electronic)):1912–1915. doi: 10.1126/science.1141453. [DOI] [PubMed] [Google Scholar]
  • 75.Hadjieconomou D, Rotkopf S, Alexandre C, Bell DM, Dickson BJ, Salecker I. Flybow: genetic multicolor cell labeling for neural circuit analysis in Drosophila melanogaster. Nat Methods. 2011;8(1548-7105 (Electronic)):260–266. doi: 10.1038/nmeth.1567. [DOI] [PubMed] [Google Scholar]
  • 76.Voziyanov Y, Konieczka JH, Stewart AF, Jayaram M. Stepwise manipulation of DNA specificity in Flp recombinase: progressively adapting Flp to individual and combinatorial mutations in its target site. J Mol Biol. 2003;326(0022-2836 (Print)):65–76. doi: 10.1016/s0022-2836(02)01364-5. [DOI] [PubMed] [Google Scholar]
  • 77.Smith MC, Brown WR, McEwan AR, Rowley PA. Site-specific recombination by phiC31 integrase and other large serine recombinases. Biochem Soc Trans. 2010;38(1470-8752 (Electronic)):388–394. doi: 10.1042/BST0380388. [DOI] [PubMed] [Google Scholar]
  • 78.Thorpe HM, Smith MC. In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. Proc Natl Acad Sci USA. 1998;95(0027-8424):5505–5510. doi: 10.1073/pnas.95.10.5505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Colloms SD, Merrick CA, Olorunniji FJ, et al. Rapid metabolic pathway assembly and modification using serine integrase site-specific recombination. Nucleic Acids Res. 2014;42(1362-4962 (Electronic)):e23. doi: 10.1093/nar/gkt1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Birling MC, Gofflot F, Warot X. Site-specific recombinases for manipulation of the mouse genome. Methods Mol Biol. 2009;561(1064-3745 (Print)):245–263. doi: 10.1007/978-1-60327-019-9_16. [DOI] [PubMed] [Google Scholar]
  • 81.Mosimann C, Puller AC, Lawson KL, Tschopp P, Amsterdam A, Zon LI. Site-directed zebrafish transgenesis into single landing sites with the phiC31 integrase system. Dev Dyn. 2013;242(1097-0177 (Electronic)):949–963. doi: 10.1002/dvdy.23989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Roberts JA, Miguel-Escalada I, Slovik KJ, et al. Targeted transgene integration overcomes variability of position effects in zebrafish. Development. 2014;141(1477-9129 (Electronic)):715–724. doi: 10.1242/dev.100347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Ni JQ, Zhou R, Czech B, et al. A genome-scale shRNA resource for transgenic RNAi in Drosophila. Nat Methods. 2011;8(1548-7105 (Electronic)):405–407. doi: 10.1038/nmeth.1592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Ejsmont RK, Sarov M, Winkler S, Lipinsk KA, Tomancak P. A toolkit for high-throughput, cross-species gene engineering in Drosophila. Nat Methods. 2009;6(1548-7105 (Electronic)):435–437. doi: 10.1038/nmeth.1334. [DOI] [PubMed] [Google Scholar]
  • 85.Venken KJT, Carlson JW, Schulze KL, et al. Versatile P[acman] BAC libraries for transgenesis studies in Drosophila melanogaster. Nat Methods. 2009;6(6):431–434. doi: 10.1038/nmeth.1331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Venken KJT, Popodi E, Holtzman SL, et al. A molecularly defined duplication set for the X chromosome of Drosophila melanogaster. Genetics. 2010;186(4):1111–1125. doi: 10.1534/genetics.110.121285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Jenett A, Rubin GM, Ngo TT, et al. A GAL4-driver line resource for Drosophila neurobiology. Cell Rep. 2012;2(2211-1247 (Electronic)):991–1001. doi: 10.1016/j.celrep.2012.09.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Bischof J, Bjorklund M, Furger E, Schertel C, Taipale J, Basler K. A versatile platform for creating a comprehensive UAS-ORFeome library in Drosophila. Development. 2013;140(1477-9129 (Electronic)):2434–2442. doi: 10.1242/dev.088757. [DOI] [PubMed] [Google Scholar]
  • 89.Bischof J, Sheils EM, Bjorklund M, Basler K. Generation of a transgenic ORFeome library in Drosophila. Nat Protoc. 2014;9(1750-2799 (Electronic)):1607–1620. doi: 10.1038/nprot.2014.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Huang J, Ghosh P, Hatfull GF, Hong Y. Successive and Targeted DNA Integrations in the Drosophila Genome by Bxb1 and {varphi}C31 Integrases. Genetics. 2011;189(1943-2631 (Electronic)):391–395. doi: 10.1534/genetics.111.129247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Yang L, Nielsen AA, Fernandez-Rodriguez J, et al. Permanent genetic memory with >1-byte capacity. Nat Methods. 2014;11(1548-7105 (Electronic)):1261–1266. doi: 10.1038/nmeth.3147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Bateman JR, Lee AM, Wu CT. Site-Specific Transformation of Drosophila via _f_C31 Integrase-Mediated Cassette Exchange. Genetics. 2006;173(0016-6731 (Print)):769–777. doi: 10.1534/genetics.106.056945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Turan S, Bode J. Site-specific recombinases: from tag-and-target- to tag-and-exchange-based genomic modifications. FASEB J. 2011;25(1530-6860 (Electronic)):4088–4107. doi: 10.1096/fj.11-186940. [DOI] [PubMed] [Google Scholar]
  • 94.Turan S, Galla M, Ernst E, et al. Recombinase-mediated cassette exchange (RMCE): traditional concepts and current challenges. J Mol Biol. 2011;407(1089-8638 (Electronic)):193–221. doi: 10.1016/j.jmb.2011.01.004. [DOI] [PubMed] [Google Scholar]
  • 95.Turan S, Zehe C, Kuehle J, Qiao J, Bode J. Recombinase-mediated cassette exchange (RMCE) - a rapidly-expanding toolbox for targeted genomic modifications. Gene. 2013;515(1879-0038 (Electronic)):1–27. doi: 10.1016/j.gene.2012.11.016. [DOI] [PubMed] [Google Scholar]
  • 96.van der Weyden L, Bradley A. Mouse chromosome engineering for modeling human disease. Annu Hum Genet. 2006;7(1527-8204 (Print)):247–276. doi: 10.1146/annurev.genom.7.080505.115741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Bischof J, Maeda RK, Hediger M, Karch F, Basler K. An optimized transgenesis system for Drosophila using germ-line-specific _f_C31 integrases. Proc Natl Acad Sci USA. 2007;104(0027-8424 (Print)):3312–3317. doi: 10.1073/pnas.0611511104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Groth AC, Fish M, Nusse R, Calos MP. Construction of transgenic Drosophila by using the site-specific integrase from phage _f_C31. Genetics. 2004;166(0016-6731):1775–1782. doi: 10.1534/genetics.166.4.1775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Horn C, Handler AM. Site-specific genomic targeting in Drosophila. Proc Natl Acad Sci USA. 2005;102(0027-8424 (Print)):12483–12488. doi: 10.1073/pnas.0504305102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Knapp JM, Chung P, Simpson JH. Generating customized transgene landing sites and multi-transgene arrays in Drosophila using phiC31 integrase. Genetics. 2015;199(1943-2631 (Electronic)):919–934. doi: 10.1534/genetics.114.173187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Ni JQ, Markstein M, Binari R, et al. Vector and parameters for targeted transgenic RNA interference in Drosophila melanogaster. Nat Methods. 2008;5(1548-7105 (Electronic)):49–51. doi: 10.1038/nmeth1146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Pfeiffer BD, Ngo TT, Hibbard KL, et al. Refinement of tools for targeted gene expression in Drosophila. Genetics. 2010;186(1943-2631 (Electronic)):735–755. doi: 10.1534/genetics.110.119917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Venken KJT, He Y, Hoskins RA, Bellen HJ. P[acman]: a BAC transgenic platform for targeted insertion of large DNA fragments in D. melanogaster. Science. 2006;314(5806):1747–1751. doi: 10.1126/science.1134426. [DOI] [PubMed] [Google Scholar]
  • 104.Szabad J, Bellen HJ, Venken KJT. An assay to detect in vivo Y chromosome loss in Drosophila wing disc cells. G3 Bethesda Md. 2012;2(9):1095–1102. doi: 10.1534/g3.112.002899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Gratz SJ, Harrison MM, Wildonger J, O’Connor-Giles KM. Precise Genome Editing of Drosophila with CRISPR RNA-Guided Cas9. Methods Mol Biol. 2015;1311(1940-6029 (Electronic)):335–348. doi: 10.1007/978-1-4939-2687-9_22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Zhang X, Ferreira IR, Schnorrer F. A simple TALEN-based protocol for efficient genome-editing in Drosophila. Methods. 2014;69(1095-9130 (Electronic)):32–37. doi: 10.1016/j.ymeth.2014.03.020. [DOI] [PubMed] [Google Scholar]
  • 107.Semprini S, Troup TJ, Kotelevtseva N, et al. Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC/PAC recombineering techniques. Nucleic Acids Res. 2007;35(1362-4962 (Electronic)):1402–1410. doi: 10.1093/nar/gkl1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Thyagarajan B, Guimaraes MJ, Groth AC, Calos MP. Mammalian genomes contain active recombinase recognition sites. Gene. 2000;244(0378-1119 (Print)):47–54. doi: 10.1016/s0378-1119(00)00008-1. [DOI] [PubMed] [Google Scholar]
  • 109.Banga SS, Boyd JB. Oligonucleotide-directed site-specific mutagenesis in Drosophila melanogaster. Proc Natl Acad Sci U S A. 1992;89(5):1735–1739. doi: 10.1073/pnas.89.5.1735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Keeler KJ, Dray T, Penney JE, Gloor GB. Gene targeting of a plasmid-borne sequence to a double-strand DNA break in Drosophila melanogaster. Mol Cell Biol. 1996;16(0270-7306 (Print)):522–528. doi: 10.1128/mcb.16.2.522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Lankenau DH, Gloor GB. In vivo gap repair in Drosophila: a one-way street with many destinations. Bioessays. 1998;20(0265-9247):317–327. doi: 10.1002/(SICI)1521-1878(199804)20:4<317::AID-BIES8>3.0.CO;2-M. [DOI] [PubMed] [Google Scholar]
  • 112.Taylor GK, Stoddard BL. Structural, functional and evolutionary relationships between homing endonucleases and proteins from their host organisms. Nucleic Acids Res. 2012;40(1362-4962 (Electronic)):5189–5200. doi: 10.1093/nar/gks226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Hsu PD, Lander ES, Zhang F. Development and Applications of CRISPR-Cas9 for Genome Engineering. Cell. 2014;157(1097-4172 (Electronic)):1262–1278. doi: 10.1016/j.cell.2014.05.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Wesolowska N, Rong YS. The past, present and future of gene targeting in Drosophila. Fly (Austin) 2010;4(1933-6942 (Electronic)):53–59. doi: 10.4161/fly.4.1.10993. [DOI] [PubMed] [Google Scholar]
  • 115.Hafez M, Hausner G. Homing endonucleases: DNA scissors on a mission. Genome. 2012;55(1480-3321 (Electronic)):553–569. doi: 10.1139/g2012-049. [DOI] [PubMed] [Google Scholar]
  • 116.Belfort M, Bonocora RP. Homing endonucleases: from genetic anomalies to programmable genomic clippers. Methods Mol Biol. 2014;1123(1940-6029 (Electronic)):1–26. doi: 10.1007/978-1-62703-968-0_1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Klug A. The discovery of zinc fingers and their applications in gene regulation and genome manipulation. Annu Rev Biochem. 2010;79(1545-4509 (Electronic)):213–231. doi: 10.1146/annurev-biochem-010909-095056. [DOI] [PubMed] [Google Scholar]
  • 118.Sander JD, Maeder ML, Joung JK. Engineering designer nucleases with customized cleavage specificities. Curr Protoc Mol Biol. 2011;Chapter 12(1934-3647 (Electronic)) doi: 10.1002/0471142727.mb1213s96. Unit 12.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Bibikova M, Golic M, Golic KG, Carroll D. Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases. Genetics. 2002;161(0016-6731):1169–1175. doi: 10.1093/genetics/161.3.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Szybalski W, Kim SC, Hasan N, Podhajska AJ. Class-IIS restriction enzymes--a review. Gene. 1991;100(0378-1119 (Print)):13–26. doi: 10.1016/0378-1119(91)90345-c. [DOI] [PubMed] [Google Scholar]
  • 121.Bibikova M, Carroll D, Segal DJ, et al. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol. 2001;21(0270-7306 (Print)):289–297. doi: 10.1128/MCB.21.1.289-297.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Beumer K, Bhattacharyya G, Bibikova M, Trautman JK, Carroll D. Efficient gene targeting in Drosophila with zinc-finger nucleases. Genetics. 2006;172(0016-6731 (Print)):2391–2403. doi: 10.1534/genetics.105.052829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Beumer KJ, Trautman JK, Christian M, et al. Comparing zinc finger nucleases and transcription activator-like effector nucleases for gene targeting in Drosophila. G3 Bethesda. 2013;3(2160-1836 (Electronic)):1717–1725. doi: 10.1534/g3.113.007260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Beumer KJ, Trautman JK, Mukherjee K, Carroll D. Donor DNA Utilization During Gene Targeting with Zinc-Finger Nucleases. G3 Genes Genomes Genetics. 2013;3(4):657–664. doi: 10.1534/g3.112.005439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Bibikova M, Beumer K, Trautman JK, Carroll D. Enhancing gene targeting with designed zinc finger nucleases. Science. 2003;300(1095-9203):764. doi: 10.1126/science.1079512. [DOI] [PubMed] [Google Scholar]
  • 126.Bozas A, Beumer KJ, Trautman JK, Carroll D. Genetic analysis of zinc-finger nuclease-induced gene targeting in Drosophila. Genetics. 2009;182(0016-6731 (Print)):641–651. doi: 10.1534/genetics.109.101329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Carroll D, Beumer KJ, Morton JJ, Bozas A, Trautman JK. Gene targeting in Drosophila and Caenorhabditis elegans with zinc-finger nucleases. Methods Mol Biol. 2008;435(1064-3745 (Print)):63–77. doi: 10.1007/978-1-59745-232-8_5. [DOI] [PubMed] [Google Scholar]
  • 128.Carroll D, Beumer KJ, Trautman JK. High-efficiency gene targeting in Drosophila with zinc finger nucleases. Methods Mol Biol. 2010;649(1940-6029 (Electronic)):271–280. doi: 10.1007/978-1-60761-753-2_17. [DOI] [PubMed] [Google Scholar]
  • 129.Cermak T, Doyle EL, Christian M, et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res. 2011;39(1362-4962 (Electronic)):e82. doi: 10.1093/nar/gkr218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Christian M, Cermak T, Doyle EL, et al. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics. 2010;186(1943-2631 (Electronic)):757–761. doi: 10.1534/genetics.110.120717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131.Li T, Huang S, Jiang WZ, et al. TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain. Nucleic Acids Res. 2011;39(1362-4962 (Electronic)):359–372. doi: 10.1093/nar/gkq704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Boch J, Bonas U. Xanthomonas AvrBs3 family-type III effectors: discovery and function. Annu Rev Phytopathol. 2010;48(0066-4286 (Print)):419–436. doi: 10.1146/annurev-phyto-080508-081936. [DOI] [PubMed] [Google Scholar]
  • 133.Boch J, Scholze H, Schornack S, et al. Breaking the code of DNA binding specificity of TAL-type III effectors. Science. 2009;326(1095-9203 (Electronic)):1509–1512. doi: 10.1126/science.1178811. [DOI] [PubMed] [Google Scholar]
  • 134.Moscou MJ, Bogdanove AJ. A simple cipher governs DNA recognition by TAL effectors. Science. 2009;326(1095-9203 (Electronic)):1501. doi: 10.1126/science.1178817. [DOI] [PubMed] [Google Scholar]
  • 135.Joung JK, Sander JD. TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol. 2013;14(1471-0080 (Electronic)):49–55. doi: 10.1038/nrm3486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Chen K, Gao C. TALENs: customizable molecular DNA scissors for genome engineering of plants. J Genet Genomics. 2013;40(1673-8527 (Print)):271–279. doi: 10.1016/j.jgg.2013.03.009. [DOI] [PubMed] [Google Scholar]
  • 137.Beurdeley M, Bietz F, Li J, et al. Compact designer TALENs for efficient genome engineering. Nat Commun. 2013;4(2041-1723 (Electronic)):1762. doi: 10.1038/ncomms2782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138.Kleinstiver BP, Wang L, Wolfs JM, et al. The I-TevI nuclease and linker domains contribute to the specificity of monomeric TALENs. G3 Bethesda. 2014;4(2160-1836 (Electronic)):1155–1165. doi: 10.1534/g3.114.011445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Beumer KJ, Carroll D. Targeted genome engineering techniques in Drosophila. Methods. 2014;68(1095-9130 (Electronic)):29–37. doi: 10.1016/j.ymeth.2013.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Katsuyama T, Akmammedov A, Seimiya M, Hess SC, Sievers C, Paro R. An efficient strategy for TALEN-mediated genome engineering in Drosophila. Nucleic Acids Res. 2013;41(1362-4962 (Electronic)):e163. doi: 10.1093/nar/gkt638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Kondo T, Sakuma T, Wada H, Akimoto-Kato A, Yamamoto T, Hayashi S. TALEN-induced gene knock out in Drosophila. Dev Growth Differ. 2014;56(1440-169X (Electronic)):86–91. doi: 10.1111/dgd.12097. [DOI] [PubMed] [Google Scholar]
  • 142.Liu J, Li C, Yu Z, et al. Efficient and specific modifications of the Drosophila genome by means of an easy TALEN strategy. J Genet Genomics. 2012;39(1673-8527 (Print)):209–215. doi: 10.1016/j.jgg.2012.04.003. [DOI] [PubMed] [Google Scholar]
  • 143.Liu J, Chen Y, Jiao R. TALEN-mediated Drosophila genome editing: protocols and applications. Methods. 2014;69(1095-9130 (Electronic)):22–31. doi: 10.1016/j.ymeth.2014.04.010. [DOI] [PubMed] [Google Scholar]
  • 144.Takasu Y, Tamura T, Sajwan S, Kobayashi I, Zurovec M. The use of TALENs for nonhomologous end joining mutagenesis in silkworm and fruit fly. Methods. 2014;69(1095-9130 (Electronic)):46–57. doi: 10.1016/j.ymeth.2014.02.014. [DOI] [PubMed] [Google Scholar]
  • 145.Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346(1095-9203 (Electronic)):1258096. doi: 10.1126/science.1258096. [DOI] [PubMed] [Google Scholar]
  • 146.Gasiunas G, Siksnys V. RNA-dependent DNA endonuclease Cas9 of the CRISPR system: Holy Grail of genome editing? Trends Micro biol. 2013;21(11):562–567. doi: 10.1016/j.tim.2013.09.001. [DOI] [PubMed] [Google Scholar]
  • 147.Mali P, Esvelt KM, Church GM. Cas9 as a versatile tool for engineering biology. Nat Methods. 2013;10(1548-7105 (Electronic)):957–963. doi: 10.1038/nmeth.2649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Sander JD, Joung JK. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol. 2014;32(1546-1696 (Electronic)):347–355. doi: 10.1038/nbt.2842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149.Sternberg SH, Doudna JA. Expanding the Biologist’s Toolkit with CRISPR-Cas9. Mol Cell. 2015;58(1097-4164 (Electronic)):568–574. doi: 10.1016/j.molcel.2015.02.032. [DOI] [PubMed] [Google Scholar]
  • 150.Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(1095-9203 (Electronic)):819–823. doi: 10.1126/science.1231143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 151.Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(1095-9203 (Electronic)):816–821. doi: 10.1126/science.1225829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152.Mali P, Yang L, Esvelt KM, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339(1095-9203 (Electronic)):823–826. doi: 10.1126/science.1232033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153.Esvelt KM, Mali P, Braff JL, Moosburner M, Yaung SJ, Church GM. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods. 2013;10(1548-7105 (Electronic)):1116–1121. doi: 10.1038/nmeth.2681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 154.Gasiunas G, Barrangou R, Horvath P, Siksnys V. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci USA. 2012;109(1091-6490 (Electronic)):E2579–E2586. doi: 10.1073/pnas.1208507109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155.Guilinger JP, Thompson DB, Liu DR. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol. 2014;32(1546-1696 (Electronic)):577–582. doi: 10.1038/nbt.2909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156.Tsai SQ, Wyvekens N, Khayter C, et al. Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol. 2014;32(1546-1696 (Electronic)):569–576. doi: 10.1038/nbt.2908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 157.Bassett AR, Liu JL. CRISPR/Cas9 and genome editing in Drosophila. J Genet Genomics. 2014;41(1673-8527 (Print)):7–19. doi: 10.1016/j.jgg.2013.12.004. [DOI] [PubMed] [Google Scholar]
  • 158.Bassett AR, Tibbit C, Ponting CP, Liu JL. Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system. Cell Rep. 2013;4(2211-1247 (Electronic)):220–228. doi: 10.1016/j.celrep.2013.06.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 159.Bottcher R, Hollmann M, Merk K, et al. Efficient chromosomal gene modification with CRISPR/cas9 and PCR-based homologous recombination donors in cultured Drosophila cells. Nucleic Acids Res. 2014;42(1362-4962 (Electronic)):e89. doi: 10.1093/nar/gku289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 160.Chen HM, Huang Y, Pfeiffer BD, Yao X, Lee T. An enhanced gene targeting toolkit for Drosophila: Golic+ Genetics. 2015;199(1943-2631 (Electronic)):683–694. doi: 10.1534/genetics.114.173716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161.Gantz VM, Bier E. Genome editing. The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations. Science. 2015;348(1095-9203 (Electronic)):442–444. doi: 10.1126/science.aaa5945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 162.Gokcezade J, Sienski G, Duchek P. Efficient CRISPR/Cas9 plasmids for rapid and versatile genome editing in Drosophila. G3 (Bethesda) 2014;4(2160-1836 (Electronic)):2279–2282. doi: 10.1534/g3.114.014126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 163.Gratz SJ, Cummings AM, Nguyen JN, et al. Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics. 2013;194(1943-2631 (Electronic)):1029–1035. doi: 10.1534/genetics.113.152710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164.Gratz SJ, Ukken FP, Rubinstein CD, et al. Highly specific and efficient CRISPR/Cas9-catalyzed homology-directed repair in Drosophila. Genetics. 2014;196(1943-2631 (Electronic)):961–971. doi: 10.1534/genetics.113.160713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 165.Kondo S, Ueda R. Highly improved gene targeting by germ line-specific Cas9 expression in Drosophila. Genetics. 2013;195(1943-2631 (Electronic)):715–721. doi: 10.1534/genetics.113.156737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 166.Lee JS, Kwak SJ, Kim J, et al. RNA-guided genome editing in Drosophila with the purified Cas9 protein. G3 (Bethesda) 2014;4(2160-1836 (Electronic)):1291–1295. doi: 10.1534/g3.114.012179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 167.Port F, Chen HM, Lee T, Bullock SL. Optimized CRISPR/Cas tools for efficient germ line and somatic genome engineering in Drosophila. Proc Natl Acad Sci USA. 2014;111(1091-6490 (Electronic)):E2967–E2976. doi: 10.1073/pnas.1405500111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 168.Ren X, Sun J, Housden BE, et al. Optimized gene editing technology for Drosophila melanogaster using germ line-specific Cas9. Proc Natl Acad Sci USA. 2013;110(1091-6490 (Electronic)):19012–19017. doi: 10.1073/pnas.1318481110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 169.Ren X, Yang Z, Xu J, et al. Enhanced specificity and efficiency of the CRISPR/Cas9 system with optimized sgRNA parameters in Drosophila. Cell Rep. 2014;9(2211-1247 (Electronic)):1151–1162. doi: 10.1016/j.celrep.2014.09.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 170.Ren X, Yang Z, Mao D, et al. Performance of the Cas9 nickase system in Drosophila melanogaster. G3 (Bethesda) 2014;4(2160-1836 (Electronic)):1955–1962. doi: 10.1534/g3.114.013821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 171.Sebo ZL, Lee HB, Peng Y, Guo Y. A simplified and efficient germ line-specific CRISPR/Cas9 system for Drosophila genomic engineering. Fly (Austin) 2014;8(1933-6942 (Electronic)):52–57. doi: 10.4161/fly.26828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 172.Xue Z, Wu M, Wen K, et al. CRISPR/Cas9 mediates efficient conditional mutagenesis in Drosophila. G3 (Bethesda) 2014;4(2160-1836 (Electronic)):2167–2173. doi: 10.1534/g3.114.014159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 173.Xue Z, Ren M, Wu M, Dai J, Rong YS, Gao G. Efficient gene knock-out and knock-in with transgenic Cas9 in Drosophila. G3 (Bethesda) 2014;4(2160-1836 (Electronic)):925–929. doi: 10.1534/g3.114.010496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 174.Yu Z, Ren M, Wang Z, et al. Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila. Genetics. 2013;195(1943-2631 (Electronic)):289–291. doi: 10.1534/genetics.113.153825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 175.Yu Z, Chen H, Liu J, et al. Various applications of TALEN- and CRISPR/Cas9-mediated homologous recombination to modify the Drosophila genome. Biol Open. 2014;3(2046-6390 (Electronic)):271–280. doi: 10.1242/bio.20147682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 176.Zhang X, Koolhaas WH, Schnorrer F. A versatile two-step CRISPR- and RMCE-based strategy for efficient genome engineering in Drosophila. G3 (Bethesda) 2014;4(2160-1836 (Electronic)):2409–2418. doi: 10.1534/g3.114.013979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 177.Kim E, Kim S, Kim DH, Choi BS, Choi IY, Kim JS. Precision genome engineering with programmable DNA-nicking enzymes. Genome Res. 2012;22(1549-5469 (Electronic)):1327–1333. doi: 10.1101/gr.138792.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 178.Ramirez CL, Certo MT, Mussolino C, et al. Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects. Nucleic Acids Res. 2012;40(1362-4962 (Electronic)):5560–5568. doi: 10.1093/nar/gks179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 179.Wang J, Friedman G, Doyon Y, et al. Targeted gene addition to a predetermined site in the human genome using a ZFN-based nicking enzyme. Genome Res. 2012;22(1549-5469 (Electronic)):1316–1326. doi: 10.1101/gr.122879.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 180.Wu Y, Gao T, Wang X, et al. TALE nickase mediates high efficient targeted transgene integration at the human multi-copy ribosomal DNA locus. Biochem Biophys Res Commun. 2014;446(1090-2104 (Electronic)):261–266. doi: 10.1016/j.bbrc.2014.02.099. [DOI] [PubMed] [Google Scholar]
  • 181.Gabsalilow L, Schierling B, Friedhoff P, Pingoud A, Wende W. Site- and strand-specific nicking of DNA by fusion proteins derived from MutH and I-SceI or TALE repeats. Nucleic Acids Res. 2013;41(1362-4962 (Electronic)):e83. doi: 10.1093/nar/gkt080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 182.Ran FA, Hsu PD, Lin CY, et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell. 2013;154(1097-4172 (Electronic)):1380–1389. doi: 10.1016/j.cell.2013.08.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 183.Shen B, Zhang W, Zhang J, et al. Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects. Nat Methods. 2014;11(1548-7105 (Electronic)):399–402. doi: 10.1038/nmeth.2857. [DOI] [PubMed] [Google Scholar]
  • 184.Chapman JR, Taylor MR, Boulton SJ. Playing the end game: DNA double-strand break repair pathway choice. Mol Cell. 2012;47(1097-4164 (Electronic)):497–510. doi: 10.1016/j.molcel.2012.07.029. [DOI] [PubMed] [Google Scholar]
  • 185.Renkawitz J, Lademann CA, Jentsch S. Mechanisms and principles of homology search during recombination. Nat Rev Mol Cell Biol. 2014;15(1471-0080 (Electronic)):369–383. doi: 10.1038/nrm3805. [DOI] [PubMed] [Google Scholar]
  • 186.Somers J, Nguyen J, Lumb C, Batterham P, Perry T. In vivo functional analysis of the Drosophila melanogaster nicotinic acetylcholine receptor Dalpha6 using the insecticide spinosad. Insect Biochem. 2015;(1879-0240 (Electronic))) doi: 10.1016/j.ibmb.2015.01.018. [DOI] [PubMed] [Google Scholar]
  • 187.Wefers B, Meyer M, Ortiz O, et al. Direct production of mouse disease models by embryo microinjection of TALENs and oligodeoxynucleotides. Proc Natl Acad Sci USA. 2013;110(1091-6490 (Electronic)):3782–3787. doi: 10.1073/pnas.1218721110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 188.Bedell VM, Wang Y, Campbell JM, et al. In vivo genome editing using a high-efficiency TALEN system. Nature. 2012;491(1476-4687 (Electronic)):114–118. doi: 10.1038/nature11537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 189.Shen B, Zhang X, Du Y, et al. Efficient knockin mouse generation by ssDNA oligonucleotides and zinc-finger nuclease assisted homologous recombination in zygotes. PLoS ONE. 2013;8(1932-6203 (Electronic)):e77696. doi: 10.1371/journal.pone.0077696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 190.Capecchi MR. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat Rev Genet. 2005;6(1471-0056 (Print)):507–512. doi: 10.1038/nrg1619. [DOI] [PubMed] [Google Scholar]
  • 191.Maggert KA, Gong WJ, Golic KG. Methods for homologous recombination in Drosophila. Methods Mol Biol. 2008;420(1064-3745 (Print)):155–174. doi: 10.1007/978-1-59745-583-1_9. [DOI] [PubMed] [Google Scholar]
  • 192.Rong YS, Golic KG. Gene targeting by homologous recombination in Drosophila. Science. 2000;288(0036-8075):2013–2018. doi: 10.1126/science.288.5473.2013. [DOI] [PubMed] [Google Scholar]
  • 193.Rong YS, Golic KG. A targeted gene knockout in Drosophila. Genetics. 2001;157(0016-6731):1307–1312. doi: 10.1093/genetics/157.3.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 194.Rong YS, Titen SW, Xie HB, et al. Targeted mutagenesis by homologous recombination in D. melanogaster. Genes Dev. 2002;16(0890-9369):1568–1581. doi: 10.1101/gad.986602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 195.Gong WJ, Golic KG. Ends-out, or replacement, gene targeting in Drosophila. Proc Natl Acad Sci USA. 2003;100(0027-8424):2556–2561. doi: 10.1073/pnas.0535280100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 196.Kurkulos M, Weinberg JM, Roy D, Mount SM. P element-mediated in vivo deletion analysis of white-apricot: deletions between direct repeats are strongly favored. Genetics. 1994;136(3):1001–1011. doi: 10.1093/genetics/136.3.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 197.McVey M, Adams M, Staeva-Vieira E, Sekelsky JJ. Evidence for multiple cycles of strand invasion during repair of double-strand gaps in Drosophila. Genetics. 2004;167(2):699–705. doi: 10.1534/genetics.103.025411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 198.Nassif N, Penney J, Pal S, Engels WR, Gloor GB. Efficient copying of nonhomologous sequences from ectopic sites via P-element-induced gap repair. Mol Cell Biol. 1994;14(3):1613–1625. doi: 10.1128/mcb.14.3.1613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 199.Huang J, Zhou W, Watson AM, Jan YN, Hong Y. Efficient ends-out gene targeting in Drosophila. Genetics. 2008;180(0016-6731 (Print)):703–707. doi: 10.1534/genetics.108.090563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 200.Huang J, Zhou W, Dong W, Watson AM, Hong Y. From the Cover: Directed, efficient, and versatile modifications of the Drosophila genome by genomic engineering. Proc Natl Acad Sci USA. 2009;106(1091-6490 (Electronic)):8284–8289. doi: 10.1073/pnas.0900641106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 201.Stoddard BL. Homing endonucleases: from microbial genetic invaders to reagents for targeted DNA modification. Structure. 2011;19(1878-4186 (Electronic)):7–15. doi: 10.1016/j.str.2010.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 202.Zhang F, Cong L, Lodato S, Kosuri S, Church GM, Arlotta P. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol. 2011;29(1546-1696 (Electronic)):149–153. doi: 10.1038/nbt.1775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 203.Juillerat A, Bertonati C, Dubois G, et al. BurrH: a new modular DNA binding protein for genome engineering. Sci Rep. 2014;4(2045-2322 (Electronic)):3831. doi: 10.1038/srep03831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 204.de Lange O, Wolf C, Dietze J, Elsaesser J, Morbitzer R, Lahaye T. Programmable DNA-binding proteins from Burkholderia provide a fresh perspective on the TALE-like repeat domain. Nucleic Acids Res. 2014;42(1362-4962 (Electronic)):7436–7449. doi: 10.1093/nar/gku329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 205.Stella S, Molina R, Lopez-Mendez B, et al. BuD, a helix-loop-helix DNA-binding domain for genome modification. Acta Crystallogr D Biol Crystallogr. 2014;70(1399-0047 (Electronic)):2042–2052. doi: 10.1107/S1399004714011183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 206.Kleinstiver BP, Prew MS, Tsai SQ, et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature. 2015;523(7561):481–485. doi: 10.1038/nature14592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 207.Hou Z, Zhang Y, Propson NE, et al. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci USA. 2013;110(1091-6490 (Electronic)):15644–15649. doi: 10.1073/pnas.1313587110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 208.Ran FA, Cong L, Yan WX, et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature. 2015;520(1476-4687 (Electronic)):186–191. doi: 10.1038/nature14299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 209.Koo T, Lee J, Kim JS. Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9. Mol Cells. 2015;38(0219-1032 (Electronic)):475–481. doi: 10.14348/molcells.2015.0103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 210.Pattanayak V, Guilinger JP, Liu DR. Determining the specificities of TALENs, Cas9, and other genome-editing enzymes. Methods Enzym. 2014;546(1557-7988 (Electronic)):47–78. doi: 10.1016/B978-0-12-801185-0.00003-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 211.Pauwels K, Podevin N, Breyer D, Carroll D, Herman P. Engineering nucleases for gene targeting: safety and regulatory considerations. N Biotechnol. 2014;31(1876-4347 (Electronic)):18–27. doi: 10.1016/j.nbt.2013.07.001. [DOI] [PubMed] [Google Scholar]
  • 212.Cradick TJ, Ambrosini G, Iseli C, Bucher P, McCaffrey AP. ZFN-site searches genomes for zinc finger nuclease target sites and off-target sites. BMC Bioinformatics. 2011;12(1471-2105 (Electronic)):152. doi: 10.1186/1471-2105-12-152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 213.Fine EJ, Cradick TJ, Zhao CL, Lin Y, Bao G. An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage. Nucleic Acids Res. 2014;42(1362-4962 (Electronic)):e42. doi: 10.1093/nar/gkt1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 214.Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA, Liu DR. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol. 2013;31(1546-1696 (Electronic)):839–843. doi: 10.1038/nbt.2673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 215.Sander JD, Ramirez CL, Linder SJ, et al. In silico abstraction of zinc finger nuclease cleavage profiles reveals an expanded landscape of off-target sites. Nucleic Acids Res. 2013;41(1362-4962 (Electronic)):e181. doi: 10.1093/nar/gkt716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 216.Qiu P, Shandilya H, D’Alessio JM, O’Connor K, Durocher J, Gerard GF. Mutation detection using Surveyor nuclease. Biotechniques. 2004;36(0736-6205 (Print)):702–707. doi: 10.2144/04364PF01. [DOI] [PubMed] [Google Scholar]
  • 217.Tsai SQ, Zheng Z, Nguyen NT, et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol. 2015;33(2):187–197. doi: 10.1038/nbt.3117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 218.O’Connor MJ, Chia W. Gene transfer in Drosophila. Methods Mol Biol. 2002;180(1064-3745 (Print)):27–36. doi: 10.1385/1-59259-178-7:027. [DOI] [PubMed] [Google Scholar]
  • 219.Venken KJT, Bellen HJ. Transgenesis upgrades for Drosophila melanogaster. Dev Camb Engl. 2007;134(20):3571–3584. doi: 10.1242/dev.005686. [DOI] [PubMed] [Google Scholar]
  • 220.Gohl DM, Silies MA, Gao XJ, et al. A versatile in vivo system for directed dissection of gene expression patterns. Nat Methods. 2011;8(1548-7105 (Electronic)):231–237. doi: 10.1038/nmeth.1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 221.Fish MP, Groth AC, Calos MP, Nusse R. Creating transgenic Drosophila by microinjecting the site-specific phiC31 integrase mRNA and a transgene-containing donor plasmid. Nat Protoc. 2007;2(1750-2799 (Electronic)):2325–2331. doi: 10.1038/nprot.2007.328. [DOI] [PubMed] [Google Scholar]
  • 222.Beumer KJ, Trautman JK, Bozas A, et al. Efficient gene targeting in Drosophila by direct embryo injection with zinc-finger nucleases. Proc Natl Acad Sci USA. 2008;105(1091-6490 (Electronic)):19821–19826. doi: 10.1073/pnas.0810475105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 223.Golic KG, Lindquist S. The FLP recombinase of yeast catalyzes site-specific recombination in the Drosophila genome. Cell. 1989;59(0092-8674):499–509. doi: 10.1016/0092-8674(89)90033-0. [DOI] [PubMed] [Google Scholar]
  • 224.Chan CC, Scoggin S, Wang D, et al. Systematic discovery of Rab GTPases with synaptic functions in Drosophila. Curr Biol. 2011;21(1879-0445 (Electronic)):1704–1715. doi: 10.1016/j.cub.2011.08.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 225.Jin EJ, Chan CC, Agi E, et al. Similarities of Drosophila rab GTPases based on expression profiling: completion and analysis of the rab-Gal4 kit. PLoS ONE. 2012;7(1932-6203 (Electronic)):e40912. doi: 10.1371/journal.pone.0040912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 226.O’keefe LV, Smibert P, Colella A, Chataway TK, Saint R, Richards RI. Know thy fly. Trends Genet. 2007;23(0168-9525 (Print)):238–242. doi: 10.1016/j.tig.2007.03.007. [DOI] [PubMed] [Google Scholar]
  • 227.Golic MM, Rong YS, Petersen RB, Lindquist SL, Golic KG. FLP-mediated DNA mobilization to specific target sites in Drosophila chromosomes. Nucleic Acids Res. 1997;25(0305-1048):3665–3671. doi: 10.1093/nar/25.18.3665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 228.Diao F, Ironfield H, Luan H, et al. Plug-and-play genetic access to drosophila cell types using exchangeable exon cassettes. Cell Rep. 2015;10(2211-1247 (Electronic)):1410–1421. doi: 10.1016/j.celrep.2015.01.059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 229.Nagarkar-Jaiswal S, Lee P-T, Campbell ME, et al. A library of MiMICs allows tagging of genes and reversible, spatial and temporal knockdown of proteins in Drosophila. eLife. 2015;4:e05338. doi: 10.7554/eLife.05338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 230.Venken KJT, Schulze KL, Haelterman NA, et al. MiMIC: a highly versatile transposon insertion resource for engineering Drosophila melanogaster genes. Nat Methods. 2011;8(9):737–743. doi: 10.1038/nmeth.1662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 231.Nagarkar-Jaiswal S, DeLuca SZ, Lee P-T, et al. A genetic toolkit for tagging intronic MiMIC containing genes. eLife. 2015;4:e08469. doi: 10.7554/eLife.08469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 232.Bateman JR, Palopoli MF, Dale ST, et al. Captured segment exchange: a strategy for custom engineering large genomic regions in Drosophila melanogaster. Genetics. 2013;193(1943-2631 (Electronic)):421–430. doi: 10.1534/genetics.112.145748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 233.Macdonald LE, Karow M, Stevens S, et al. Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes. Proc Natl Acad Sci USA. 2014;111(1091-6490 (Electronic)):5147–5152. doi: 10.1073/pnas.1323896111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 234.Ruiz-Herrera A, Farre M, Robinson TJ. Molecular cytogenetic and genomic insights into chromosomal evolution. Hered Edinb. 2012;108(1365-2540 (Electronic)):28–36. doi: 10.1038/hdy.2011.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 235.Wallace HA, Marques-Kranc F, Richardson M, et al. Manipulating the mouse genome to engineer precise functional syntenic replacements with human sequence. Cell. 2007;128(0092-8674 (Print)):197–209. doi: 10.1016/j.cell.2006.11.044. [DOI] [PubMed] [Google Scholar]
  • 236.Willinger T, Rongvaux A, Takizawa H, et al. Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc Natl Acad Sci USA. 2011;108(1091-6490 (Electronic)):2390–2395. doi: 10.1073/pnas.1019682108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 237.Cook RK, Deal ME, Deal JA, et al. A new resource for characterizing X-linked genes in Drosophila melanogaster: systematic coverage and subdivision of the X chromosome with nested, Y-linked duplications. Genetics. 2010;186(1943-2631 (Electronic)):1095–1109. doi: 10.1534/genetics.110.123265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 238.Cook RK, Christensen SJ, Deal JA, et al. The generation of chromosomal deletions to provide extensive coverage and subdivision of the Drosophila melanogaster genome. Genome Biol. 2012;13(1465-6914 (Electronic)):R21. doi: 10.1186/gb-2012-13-3-r21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 239.Golic KG, Golic MM. Engineering the Drosophila genome: chromosome rearrangements by design. Genetics. 1996;144(0016-6731):1693–1711. doi: 10.1093/genetics/144.4.1693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 240.Hattori D, Demir E, Kim HW, Viragh E, Zipursky SL, Dickson BJ. Dscam diversity is essential for neuronal wiring and self-recognition. Nature. 2007;449(1476-4687 (Electronic)):223–227. doi: 10.1038/nature06099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 241.Hattori D, Chen Y, Matthews BJ, et al. Robust discrimination between self and non-self neurites requires thousands of Dscam1 isoforms. Nature. 2009;461(1476-4687 (Electronic)):644–648. doi: 10.1038/nature08431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 242.Choi CM, Vilain S, Langen M, et al. Conditional mutagenesis in Drosophila. Science. 2009;324(1095-9203 (Electronic)):54. doi: 10.1126/science.1168275. [DOI] [PubMed] [Google Scholar]
  • 243.Demir E, Dickson BJ. fruitless splicing specifies male courtship behavior in Drosophila. Cell. 2005;121(0092-8674 (Print)):785–794. doi: 10.1016/j.cell.2005.04.027. [DOI] [PubMed] [Google Scholar]
  • 244.Lloyd TE, Machamer J, O’Hara K, et al. The p150(Glued) CAP-Gly domain regulates initiation of retrograde transport at synaptic termini. Neuron. 2012;74(1097-4199 (Electronic)):344–360. doi: 10.1016/j.neuron.2012.02.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 245.Schutte RJ, Schutte SS, Algara J, et al. Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current. J Neuro physiol. 2014;112(1522-1598 (Electronic)):903–912. doi: 10.1152/jn.00135.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 246.Sun L, Gilligan J, Staber C, et al. A knock-in model of human epilepsy in Drosophila reveals a novel cellular mechanism associated with heat-induced seizure. J Neurosci. 2012;32(1529-2401 (Electronic)):14145–14155. doi: 10.1523/JNEUROSCI.2932-12.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 247.Spitzweck B, Brankatschk M, Dickson BJ. Distinct protein domains and expression patterns confer divergent axon guidance functions for Drosophila Robo receptors. Cell. 2010;140(1097-4172 (Electronic)):409–420. doi: 10.1016/j.cell.2010.01.002. [DOI] [PubMed] [Google Scholar]
  • 248.Alexandre C, Baena-Lopez A, Vincent JP. Patterning and growth control by membrane-tethered Wingless. Nature. 2014;505(1476-4687 (Electronic)):180–185. doi: 10.1038/nature12879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 249.Brankatschk M, Dickson BJ. Netrins guide Drosophila commissural axons at short range. Nat Neurosci. 2006;9(1097-6256 (Print)):188–194. doi: 10.1038/nn1625. [DOI] [PubMed] [Google Scholar]
  • 250.Seum C, Reo E, Peng H, Rauscher FJ, III, Spierer P, Bontron S. Drosophila SETDB1 is required for chromosome 4 silencing. PLoS Genet. 2007;3(1553-7404 (Electronic)):e76. doi: 10.1371/journal.pgen.0030076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 251.Vilain S, Vanhauwaert R, Maes I, et al. Fast and efficient Drosophila melanogaster gene knock-ins using MiMIC transposons. G3 (Bethesda) 2014;4(2160-1836 (Electronic)):2381–2387. doi: 10.1534/g3.114.014803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 252.Skarnes WC, Rosen B, West AP, et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature. 2011;474(1476-4687 (Electronic)):337–342. doi: 10.1038/nature10163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 253.Gnerer JP, Venken KJ, Dierick HA. Gene-specific cell labeling using MiMIC transposons. Nucleic Acids Res. 2015;43(1362-4962 (Electronic)):e56. doi: 10.1093/nar/gkv113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 254.Manoli DS, Foss M, Villella A, Taylor BJ, Hall JC, Baker BS. Male-specific fruitless specifies the neural substrates of Drosophila courtship behaviour. Nature. 2005;436(1476-4687 (Electronic)):395–400. doi: 10.1038/nature03859. [DOI] [PubMed] [Google Scholar]
  • 255.Stockinger P, Kvitsiani D, Rotkopf S, Tirian L, Dickson BJ. Neural circuitry that governs Drosophila male courtship behavior. Cell. 2005;121(0092-8674 (Print)):795–807. doi: 10.1016/j.cell.2005.04.026. [DOI] [PubMed] [Google Scholar]
  • 256.Crown KN, Sekelsky J. Targeted gene replacement in Drosophila goes the distance. Genetics. 2013;193(1943-2631 (Electronic)):377–381. doi: 10.1534/genetics.112.148379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 257.Ryder E, Blows F, Ashburner M, et al. The DrosDel collection: a set of P-element insertions for generating custom chromosomal aberrations in Drosophila melanogaster. Genetics. 2004;167(0016-6731):797–813. doi: 10.1534/genetics.104.026658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 258.Thibault ST, Singer MA, Miyazaki WY, et al. A complementary transposon tool kit for Drosophila melanogaster using P and piggyBac. Nat Genet. 2004;36(1061-4036):283–287. doi: 10.1038/ng1314. [DOI] [PubMed] [Google Scholar]
  • 259.Huynen L, Millar CD, Lambert DM. Resurrecting ancient animal genomes: the extinct moa and more. Bioessays. 2012;34(1521-1878 (Electronic)):661–669. doi: 10.1002/bies.201200040. [DOI] [PubMed] [Google Scholar]
  • 260.Pask AJ, Behringer RR, Renfree MB. Resurrection of DNA function in vivo from an extinct genome. PLoS ONE. 2008;3(1932-6203 (Electronic)):e2240. doi: 10.1371/journal.pone.0002240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 261.Clark AG, Eisen MB, Smith DR, et al. Evolution of genes and genomes on the Drosophila phylogeny. Nature. 2007;450(1476-4687 (Electronic)):203–218. doi: 10.1038/nature06341. [DOI] [PubMed] [Google Scholar]
  • 262.Stark A, Lin MF, Kheradpour P, et al. Discovery of functional elements in 12 Drosophila genomes using evolutionary signatures. Nature. 2007;450(1476-4687 (Electronic)):219–232. doi: 10.1038/nature06340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 263.Ejsmont RK, Bogdanzaliewa M, Lipinski KA, Tomancak P. Production of fosmid genomic libraries optimized for liquid culture recombineering and cross-species transgenesis. Methods Mol Biol Clifton NJ. 2011;772:423–443. doi: 10.1007/978-1-61779-228-1_25. [DOI] [PubMed] [Google Scholar]
  • 264.Kondo S, Booker M, Perrimon N. Cross-species RNAi rescue platform in Drosophila melanogaster. Genetics. 2009;183(1943-2631 (Electronic)):1165–1173. doi: 10.1534/genetics.109.106567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 265.Richards S, Liu Y, Bettencourt BR, et al. Comparative genome sequencing of Drosophila pseudoobscura: chromosomal, gene, and cis-element evolution. Genome Res. 2005;15(1088-9051 (Print)):1–18. doi: 10.1101/gr.3059305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 266.Hoskins RA, Nelson CR, Berman BP, et al. A BAC-based physical map of the major autosomes of Drosophila melanogaster. Science. 2000;287(0036-8075):2271–2274. doi: 10.1126/science.287.5461.2271. [DOI] [PubMed] [Google Scholar]
  • 267.Murakami K, Toyoda A, Hattori M, et al. BAC library construction and BAC end sequencing of five Drosophila species: the comparative map with the D. melanogaster genome. Genes Genet. 2008;83(1341-7568 (Print)):245–256. doi: 10.1266/ggs.83.245. [DOI] [PubMed] [Google Scholar]
  • 268.Osoegawa K, Vessere GM, Li SC, et al. BAC clones generated from sheared DNA. Genomics. 2007;89(0888-7543 (Print)):291–299. doi: 10.1016/j.ygeno.2006.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 269.Song X, Goicoechea JL, Ammiraju JSS, et al. The 19 genomes of Drosophila: a BAC library resource for genus-wide and genome-scale comparative evolutionary research. Genetics. 2011;187(4):1023–1030. doi: 10.1534/genetics.111.126540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 270.Xie HB, Golic KG. Gene deletions by ends-in targeting in Drosophila melanogaster. Genetics. 2004;168(0016-6731 (Print)):1477–1489. doi: 10.1534/genetics.104.030882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 271.Parks AL, Cook KR, Belvin M, et al. Systematic generation of high-resolution deletion coverage of the Drosophila melanogaster genome. Nat Genet. 2004;36(1061-4036):288–292. doi: 10.1038/ng1312. [DOI] [PubMed] [Google Scholar]
  • 272.Ryder E, Ashburner M, Bautista-Llacer R, et al. The DrosDel deletion collection: a Drosophila genomewide chromosomal deficiency resource. Genetics. 2007;177(0016-6731 (Print)):615–629. doi: 10.1534/genetics.107.076216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 273.Gong WJ, Golic KG. Genomic deletions of the Drosophila melanogaster Hsp70 genes. Genetics. 2004;168(0016-6731 (Print)):1467–1476. doi: 10.1534/genetics.104.030874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 274.Chen F, Pruett-Miller SM, Huang Y, et al. High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat Methods. 2011;8(1548-7105 (Electronic)):753–755. doi: 10.1038/nmeth.1653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 275.Xiao A, Wang Z, Hu Y, et al. Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish. Nucleic Acids Res. 2013;41(1362-4962 (Electronic)):e141. doi: 10.1093/nar/gkt464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 276.Innan H, Kondrashov F. The evolution of gene duplications: classifying and distinguishing between models. Nat Rev Genet. 2010;11(1471-0064 (Electronic)):97–108. doi: 10.1038/nrg2689. [DOI] [PubMed] [Google Scholar]
  • 277.Sasaki M, Lange J, Keeney S. Genome destabilization by homologous recombination in the germ line. Nat Rev Mol Cell Biol. 2010;11(1471-0080 (Electronic)):182–195. doi: 10.1038/nrm2849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 278.Ashburner M, Golic KG, Hawley RS. Drosophila: A Laboratory Handbook. Second Edition. Cold Spring Harbor Laboratory Press; 2005. [Google Scholar]
  • 279.Klysik J, Dinh C, Bradley A. Two new mouse chromosome 11 balancers. Genomics. 2004;83(0888-7543 (Print)):303–310. doi: 10.1016/j.ygeno.2003.08.011. [DOI] [PubMed] [Google Scholar]
  • 280.Nishijima I, Mills A, Qi Y, Mills M, Bradley A. Two new balancer chromosomes on mouse chromosome 4 to facilitate functional annotation of human chromosome 1p. Genesis. 2003;36(1526-954X (Print)):142–148. doi: 10.1002/gene.10207. [DOI] [PubMed] [Google Scholar]
  • 281.Zheng B, Sage M, Cai WW, et al. Engineering a mouse balancer chromosome. Nat Genet. 1999;22(1061-4036 (Print)):375–378. doi: 10.1038/11949. [DOI] [PubMed] [Google Scholar]
  • 282.Bunting SF, Nussenzweig A. End-joining, translocations and cancer. Nat Rev Cancer. 2013;13(1474-1768 (Electronic)):443–454. doi: 10.1038/nrc3537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 283.Roukos V, Misteli T. The biogenesis of chromosome translocations. Nat Cell Biol. 2014;16(1476-4679 (Electronic)):293–300. doi: 10.1038/ncb2941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 284.Brunet E, Simsek D, Tomishima M, et al. Chromosomal translocations induced at specified loci in human stem cells. Proc Natl Acad Sci U S A. 2009;106(26):10620–10625. doi: 10.1073/pnas.0902076106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 285.Piganeau M, Ghezraoui H, De Cian A, et al. Cancer translocations in human cells induced by zinc finger and TALE nucleases. Genome Res. 2013;23(7):1182–1193. doi: 10.1101/gr.147314.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 286.Torres R, Martin MC, Garcia A, Cigudosa JC, Ramirez JC, Rodriguez-Perales S. Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system. Nat Commun. 2014;5(2041-1723 (Electronic)):3964. doi: 10.1038/ncomms4964. [DOI] [PubMed] [Google Scholar]
  • 287.Xu T, Rubin GM. Analysis of genetic mosaics in developing and adult Drosophila tissues. Development. 1993;117(0950-1991):1223–1237. doi: 10.1242/dev.117.4.1223. [DOI] [PubMed] [Google Scholar]
  • 288.Griffin R, Sustar A, Bonvin M, et al. The twin spot generator for differential Drosophila lineage analysis. Nat Methods. 2009;6(1548-7105 (Electronic)):600–602. doi: 10.1038/nmeth.1349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 289.Lee T, Luo L. Mosaic analysis with a repressible cell marker for studies of gene function in neuronal morphogenesis. Neuron. 1999;22(0896-6273):451–461. doi: 10.1016/s0896-6273(00)80701-1. [DOI] [PubMed] [Google Scholar]
  • 290.Lee T, Winter C, Marticke SS, Lee A, Luo L. Essential roles of Drosophila RhoA in the regulation of neuroblast proliferation and dendritic but not axonal morphogenesis. Neuron. 2000;25(0896-6273):307–316. doi: 10.1016/s0896-6273(00)80896-x. [DOI] [PubMed] [Google Scholar]
  • 291.Potter CJ, Tasic B, Russler EV, Liang L, Luo L. The Q system: a repressible binary system for transgene expression, lineage tracing, and mosaic analysis. Cell. 2010;141(1097-4172 (Electronic)):536–548. doi: 10.1016/j.cell.2010.02.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 292.Yu HH, Chen CH, Shi L, Huang Y, Lee T. Twin-spot MARCM to reveal the developmental origin and identity of neurons. Nat Neurosci. 2009;12(1546-1726 (Electronic)):947–953. doi: 10.1038/nn.2345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 293.Remy S, Tesson L, Menoret S, et al. Efficient gene targeting by homology-directed repair in rat zygotes using TALE nucleases. Genome Res. 2014;24(1549-5469 (Electronic)):1371–1383. doi: 10.1101/gr.171538.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 294.Markstein M, Pitsouli C, Villalta C, Celniker SE, Perrimon N. Exploiting position effects and the gypsy retrovirus insulator to engineer precisely expressed transgenes. Nat Genet. 2008;40(1546-1718 (Electronic)):476–483. doi: 10.1038/ng.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 295.Ni JQ, Liu LP, Binari R, et al. A Drosophila resource of transgenic RNAi lines for neurogenetics. Genetics. 2009;182(1943-2631 (Electronic)):1089–1100. doi: 10.1534/genetics.109.103630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 296.Pfeiffer BD, Jenett A, Hammonds AS, et al. Tools for neuroanatomy and neurogenetics in Drosophila. Proc Natl Acad Sci USA. 2008;105(1091-6490 (Electronic)):9715–9720. doi: 10.1073/pnas.0803697105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 297.Sharan SK, Thomason LC, Kuznetsov SG, Court DL. Recombineering: a homologous recombination-based method of genetic engineering. Nat Protoc. 2009;4(1750-2799 (Electronic)):206–223. doi: 10.1038/nprot.2008.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 298.Cande J, Stern DL, Morita T, Prud’homme B, Gompel N. Looking under the lamp post: neither fruitless nor doublesex has evolved to generate divergent male courtship in Drosophila. Cell Rep. 2014;8(2211-1247 (Electronic)):363–370. doi: 10.1016/j.celrep.2014.06.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 299.Riddle NC, Shaffer CD, Elgin SC. A lot about a little dot - lessons learned from Drosophila melanogaster chromosome 4. Biochem Biol. 2009;87(0829-8211 (Print)):229–241. doi: 10.1139/o08-119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 300.Baena-Lopez LA, Alexandre C, Mitchell A, Pasakarnis L, Vincent JP. Accelerated homologous recombination and subsequent genome modification in Drosophila. Development. 2013;140(1477-9129 (Electronic)):4818–4825. doi: 10.1242/dev.100933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 301.Gao G, McMahon C, Chen J, Rong YS. A powerful method combining homologous recombination and site-specific recombination for targeted mutagenesis in Drosophila. Proc Natl Acad Sci USA. 2008;105(1091-6490 (Electronic)):13999–14004. doi: 10.1073/pnas.0805843105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 302.Iampietro C, Gummalla M, Mutero A, Karch F, Maeda RK. Initiator elements function to determine the activity state of BX-C enhancers. PLoS Genet. 2010;6(1553-7404 (Electronic)):e1001260. doi: 10.1371/journal.pgen.1001260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 303.Weng R, Chen YW, Bushati N, Cliffe A, Cohen SM. Recombinase-mediated cassette exchange provides a versatile platform for gene targeting: knockout of miR-31b. Genetics. 2009;183(1943-2631 (Electronic)):399–402. doi: 10.1534/genetics.109.105213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 304.Wesolowska N, Rong YS. Long-range targeted manipulation of the Drosophila genome by site-specific integration and recombinational resolution. Genetics. 2013;193(1943-2631 (Electronic)):411–419. doi: 10.1534/genetics.112.145631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 305.Chen YW, Weng R, Cohen SM. Protocols for use of homologous recombination gene targeting to produce microRNA mutants in Drosophila. Methods Mol Biol. 2011;732(1940-6029 (Electronic)):99–120. doi: 10.1007/978-1-61779-083-6_8. [DOI] [PubMed] [Google Scholar]
  • 306.Gratz SJ, Wildonger J, Harrison MM, O’Connor-Giles KM. CRISPR/Cas9-mediated genome engineering and the promise of designer flies on demand. Fly Austin. 2013;7(1933-6942 (Electronic)):249–255. doi: 10.4161/fly.26566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 307.Schon EA, DiMauro S, Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nat Rev Genet. 2012;13(1471-0064 (Electronic)):878–890. doi: 10.1038/nrg3275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 308.Gammage PA, Rorbach J, Vincent AI, Rebar EJ, Minczuk M. Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations. EMBO Mol Med. 2014;6(1757-4684 (Electronic)):458–466. doi: 10.1002/emmm.201303672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 309.Day A, Goldschmidt-Clermont M. The chloroplast transformation toolbox: selectable markers and marker removal. Plant Biotechnol J. 2011;9(1467-7652 (Electronic)):540–553. doi: 10.1111/j.1467-7652.2011.00604.x. [DOI] [PubMed] [Google Scholar]
  • 310.Bernardi G, Wiley EO, Mansour H, et al. The fishes of Genome 10K. Mar Genomics. 2012;7(1876-7478 (Electronic)):3–6. doi: 10.1016/j.margen.2012.02.002. [DOI] [PubMed] [Google Scholar]
  • 311.Genome 10K Community of Scientists. Genome 10K: a proposal to obtain whole-genome sequence for 10,000 vertebrate species. J Hered. 2009;100(1465-7333 (Electronic)):659–674. doi: 10.1093/jhered/esp086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 312.i5K Consortium. The i5K Initiative: advancing arthropod genomics for knowledge, human health, agriculture, and the environment. J Hered. 2013;104(1465-7333 (Electronic)):595–600. doi: 10.1093/jhered/est050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 313.Poelchau M, Childers C, Moore G, et al. The i5k Workspace@NAL--enabling genomic data access, visualization and curation of arthropod genomes. Nucleic Acids Res. 2015;43(Database issue):D714–D719. doi: 10.1093/nar/gku983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 314.Abzhanov A, Extavour CG, Groover A, et al. Are we there yet? Tracking the development of new model systems. Trends Genet. 2008;24(0168-9525 (Print)):353–360. doi: 10.1016/j.tig.2008.04.002. [DOI] [PubMed] [Google Scholar]
  • 315.Siomi H. It’s time to exploit your favorite quirky organism with new technologies. EMBO Rep. 2014;15(1469-3178 (Electronic)):620–621. doi: 10.15252/embr.201438955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 316.Dietzl G, Chen D, Schnorrer F, et al. A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature. 2007;448(1476-4687 (Electronic)):151–156. doi: 10.1038/nature05954. [DOI] [PubMed] [Google Scholar]
  • 317.Green EW, Fedele G, Giorgini F, Kyriacou CP. A Drosophila RNAi collection is subject to dominant phenotypic effects. Nat Methods. 2014;11(1548-7105 (Electronic)):222–223. doi: 10.1038/nmeth.2856. [DOI] [PubMed] [Google Scholar]

RESOURCES